topic0
P NOS [aapp, imft] 0.0119436780301
treatment [ftcn] 0.0107304606972
Study [mnob] 0.00768803643659
Group [idcn] 0.00533859435919
Cardiovascular disease [dsyn] 0.00491638238085
Compared [acty] 0.00484111172842
Methods [inpr] 0.00450267235024
Women [popg] 0.00395676695568
Increased [qnco] 0.00394305713259
CARDIOVASCULAR [bdsy] 0.00363812099606
Trial [resa] 0.00358003371052
included [ftcn] 0.00336095169092
Mortality [qnco] 0.00318483636438
Age [orga] 0.00313872498291
radiotherapy [inpr] 0.00300383542461
Based [ftcn] 0.00275155279988
Conclusions [idcn] 0.00269613408319
Men [popg] 0.00248135638065
risk factors [qnco] 0.0024408823179
Including [ftcn] 0.00243560925052
treated [topp] 0.00238629250703
Survival [acty] 0.00238575326993
N NOS [aapp, imft] 0.0023716660413
effects [qlco] 0.00229719625731
Hazard Ratio [qnco] 0.00219350074052
Hypertension [dsyn] 0.00216396232423
Suggest [idcn] 0.00216188349691
Stroke [dsyn] 0.00213151079797
Management [ocac] 0.00212776784247
Surgery [bmod] 0.00212551487266
Efficacy [qlco] 0.00209135688875
Cardiac [bpoc] 0.00207093689845
therapy [ftcn] 0.00206885420421
Association [menp] 0.002014611717
Diabetes [dsyn] 0.00196378357696
participants [popg] 0.00193268034274
Induced [ftcn] 0.00190199918511
Sclerotherapy [topp] 0.00187072032881
Present [qnco] 0.00180766475507
IMPACT [gngm] 0.00179007578071
Performed [ftcn] 0.00175302251912
Odds Ratio [qnco] 0.00172730860683
Quality [qlco] 0.00171836137402
effective [qlco] 0.00165080784963
cardiovascular events [fndg] 0.00162877147694
condition [dsyn] 0.00162488182318
Life [idcn] 0.00158711319546
Breast Cancer [neop] 0.00158710485449
Cases [ftcn] 0.0015775124576
Dose [qnco] 0.00156594495841
Levels [qlco] 0.00155608336424
Evaluated [ftcn] 0.00152610730378
Health [idcn] 0.00151950891838
Statins [orch, phsu] 0.0015176514782
Heart [bpoc] 0.00151031094813
months [tmco] 0.00150337349099
Specific [qlco] 0.00147668848612
Heart failure [dsyn] 0.00147249082073
Reported [inpr] 0.00145586452387
Therapeutic [topp] 0.00140034664778
baseline [bodm] 0.00139262824925
Prevention [topp] 0.00139075961608
Metabolic syndrome [dsyn] 0.00137876826007
Assessed [acty] 0.00137801554771
Drug [phsu] 0.0013774667618
Children [aggp] 0.00137224560271
High Risk [qlco] 0.00137215983317
Objective [inpr] 0.00136941208118
coronary artery disease [dsyn] 0.00136933026194
coronary heart disease [dsyn] 0.00136837200519
Observed [ftcn] 0.00130895775201
Reduced [qlco] 0.00130579675619
search [inpr] 0.00129562362185
Care [acty] 0.00129149078942
Available [ftcn] 0.00128970021371
Purpose [ftcn] 0.00127392833831
lesions [fndg] 0.00125650632714
Subject [grup] 0.00125435483409
Statin [orch, phsu] 0.001245723329
practice [menp] 0.00124493948337
Venous malformation [anab] 0.00124337162258
Update [tmco] 0.00123911579243
Range [qnco] 0.00122744312816
Evaluate [ftcn] 0.00122162312771
Current [tmco] 0.00120755927582
Myocardial Infarction [dsyn] 0.00119798222571
Target [ftcn] 0.00118059472526
Several [qnco] 0.00117817948725
Complications [patf] 0.00116913653085
Hormone replacement therapy [topp] 0.00116869774103
Prognostic Factor [clna] 0.00116610788561
Improvement [cnce] 0.00116457269129
Adjusted [ftcn] 0.001159396612
strategies [menp] 0.00114993095908
Diagnosed [fndg] 0.00113478392044
Improved [qlco] 0.00112798500775
Guidelines [inpr] 0.00112119816898
Reserve [acty] 0.00111192119869
Need [qlco] 0.0011018219799
GY [geoa] 0.00109669958545
Measured [qlco] 0.00109514928455
Benefit [qnco] 0.00109265873435
Score [qnco] 0.00108744617553
Receive [qlco] 0.00108682325537
PREVENT [phsu] 0.00108566247588
Blood Pressure [orgf] 0.00107621797902
intervention [hlca] 0.00106040783029
Primary [qlco] 0.00105809543254
Medical [ftcn] 0.00105089062526
People [popg] 0.00104981013973
Mechanisms [ftcn] 0.0010492866675
findings [ftcn] 0.00104285454129
Conduct [inbe] 0.00104216051505
Design [acty] 0.00103783784785
Estimated [qnco] 0.00102802272311
Following [tmco] 0.0010264426845
Authors [prog] 0.00101944738882
Controlled [ftcn] 0.00101377612097
Atherosclerosis [dsyn] 0.00100730470071
Drug Therapy [topp] 0.00100641805969
Information [idcn] 0.0010054217282
Main [qlco] 0.000995458247126
Acute Coronary Syndrome [dsyn] 0.000993658140575
Irradiation [npop] 0.000989728436035
experience [menp] 0.00098848091915
Future [tmco] 0.000983426748542
objectives [inpr] 0.000983171096995
Effectiveness [qlco] 0.000982557720669
Make [ftcn] 0.000980381210248
Issue [fndg] 0.00097644480467
Events [evnt] 0.000974420917242
Approach [spco] 0.00097400268877
Published [ocac] 0.00097395837583
Combined [qlco] 0.000968055611943
Young [tmco] 0.000966662222462
Characteristics [qlco] 0.000966330410236
Often [tmco] 0.00096041856194
Large [qnco] 0.000948541305082
Old [tmco] 0.000947076020812
Atrial Fibrillation [patf] 0.000945812394892
Central [spco] 0.000943929289383
Limited [ftcn] 0.0009393994459
considered [idcn] 0.000924691584738
Needed [qlco] 0.000922800551956
placebo [topp] 0.00091886488782
Radiation [npop] 0.000915651825771
postmenopausal [tmco] 0.000909163368925
Combination [qlco] 0.000907228539619
Identified [qlco] 0.000902490872137
Cost Effectiveness [qnco] 0.000902045648501
Increasing [ftcn] 0.000899558219572
Article [inpr] 0.000893481984243
Survivors [podg] 0.000892973910398
Comorbidities [idcn] 0.00089157109271
ischaemic heart disease [dsyn] 0.000891147603518
function [phsf] 0.000888787515696
Response [orga] 0.000888317570223
Well [qlco] 0.000882262960938
Diseases [dsyn] 0.000881497812378
Obesity [dsyn] 0.000877083330397
Confidence Intervals [qnco] 0.000876866729763
Smoking [inbe] 0.000875901447238
interventions [hlca] 0.000873495789602
Aspirin [orch, phsu] 0.000872383697601
Previous [tmco] 0.000867300453217
Exercise [dora] 0.000866122551421
Literature [inpr] 0.000866042915979
Five [qnco] 0.000860213069561
Estrogen [horm, phsu, strd] 0.000859370269579
chronic [tmco] 0.000841585780828
Safety [hcpp] 0.000837607084446
Last [qlco] 0.00083208583282
vascular [bpoc] 0.000831034934115
Chronic kidney disease [dsyn] 0.000828947238861
Index [inpr] 0.000819918035332
Physicians [prog] 0.000816679990562
Known [qlco] 0.00081589274238
Evaluation [ftcn] 0.000810771480529
Values [qlco] 0.00081015827981
Received [qlco] 0.000807016817442
Long [qlco] 0.000802631617691
Risks [qlco] 0.000798514058799
Treatments [topp] 0.000793882701592
Understanding [menp] 0.000793427700752
days [tmco] 0.000788113759796
acute [tmco] 0.00078761748415
randomized [resa] 0.000786766323315
Proportion [qnco] 0.000785196717095
Drugs [phsu] 0.000785043289488
System [ftcn] 0.000780639692103
Heart disease [dsyn] 0.000777512763769
Established [qlco] 0.000776942447552
Moderate [qlco] 0.000773958697028
Single [popg] 0.000771311077686
Multiple [qnco] 0.000769931210319
Small [qnco] 0.000766426215692
Adherence [ftcn] 0.000758160021611
Benefits [qnco] 0.000754721616642
Parameters [fndg] 0.000754094066179
Ratio [qnco] 0.000752037063338
strategy [menp] 0.000742284648918
Required [ftcn] 0.000740667844396
Appropriate [qlco] 0.000739341936932
Functional [ftcn] 0.000737820585727
Severe [qlco] 0.000736828355018
symptoms [ftcn] 0.000736329122725
Support [medd] 0.000735636391114
patient care [hlca] 0.00072954073581
LTD [ortf] 0.000728247852482
setting [ftcn] 0.000728002924124
Hospitalization [hlca] 0.000726529955184
reduction [npop] 0.000725174399603
Average [qnco] 0.000720710804657
Select [acty] 0.000720350666619
Sex [orgf] 0.000716454685813
C-reactive protein [aapp, imft] 0.000713975624692
Decrease [qlco] 0.000713458862247
History [ocdi] 0.000712201556177
Prostate Cancer [neop] 0.000704334453787
Center [spco] 0.000703878907435
Medications [phsu] 0.000702563669409
Address [inpr] 0.000696791848588
Plasma [bdsu] 0.00069319729429
Assessment [hlca] 0.000692037091087
Morbidity [qnco] 0.000691243674206
Additional [ftcn] 0.000690831854063
Menopause [phsf] 0.000688242771642
Elderly [popg] 0.000687942605284
Vascular Malformations [anab] 0.000686202167271
Reducing [qlco] 0.000682611774751
Few [qnco] 0.000681306858427
Decreased [qnco] 0.000679769675585
Profile [lbpr] 0.000671312039456
Venous Thromboembolism [patf] 0.000670440887138
Adult [aggp] 0.00066588778598
Medication [phsu] 0.000665454733095
Local [spco] 0.000663406770892
Complex [qlco] 0.000662436684872
Polypharmacy [fndg] 0.000661888992942
Lung Cancer [neop] 0.000661137435071
Diabetes Mellitus [dsyn] 0.000660907204658
Likely [qlco] 0.000657819990732
Stage [tmco] 0.000656251210624
Independent [idcn] 0.00065413302915
adverse events [fndg] 0.000653403358283
rats [mamm] 0.000651082519884
Exposure NOS [inpo] 0.000650013707964
Defined [cnce] 0.000649057420798
Acute myocardial infarction [dsyn] 0.000646420760772
Associations [menp] 0.000643626241924
Report [inpr] 0.000643166390626
Body Mass Index [diap] 0.000642614205041
Relative [famg] 0.00064029581793
coronary [bpoc] 0.000635923933837
Postoperative [tmco] 0.000633158081746
Bleeding [patf] 0.000631386681016
heart rate [clna] 0.000627233453982
free [ftcn] 0.000626592443005
randomized controlled trials [inpr, resa] 0.000626235659087
Take [hlca] 0.000625365027358
Normal [qlco] 0.000622707939987
Extracted [topp] 0.000622456116987
Aged [orga] 0.000622331823485
national [inpr] 0.00062164601089
Hospital [hcro, mnob] 0.000621312554375
Lipid [lipd] 0.000620419273995
Post [tmco] 0.000620217174418
Help [socb] 0.000617077232392
Chemotherapy [topp] 0.000615262072669
Obtained [ftcn] 0.000613320571666
Users [humn] 0.000613314082942
Optimal [qlco] 0.000612802634162
Diagnostic [fndg] 0.000611716884395
Focus [spco] 0.000610930205918
Searched [acty] 0.000609751372711
Imaging [diap] 0.000609227414469
Cardiovascular Diseases [dsyn] 0.000608828330287
Correlation [qlco] 0.000608731593678
Relationship [qlco] 0.000608052651451
Relevant [qlco] 0.000607906096208
Female [fndg] 0.000607302842826
Database [inpr] 0.000606469826412
Area [geoa] 0.000605889701455
Androgen Deprivation Therapy [topp] 0.000605017832681
In [qnco] 0.000603666491284
Adults [aggp] 0.000601308172518
lowering [spco] 0.000599783457823
Metabolic [ftcn] 0.000599623652786
Involving [ftcn] 0.00059897683649
Head [blor] 0.000598396766003
Pain [sosy] 0.000597325155651
Congenital heart disease [cgab, dsyn] 0.000594943862143
prognostic [inpr] 0.000591754757807
Review, Systematic [inpr] 0.000591209535344
lack [qlco] 0.000591094023134
M NOS [aapp, imft] 0.000589515324171
Alone [qnco] 0.000589232729891
Leading [tmco] 0.000587006173953
Recommended [idcn] 0.000585711244039
Program [cnce] 0.000584052350016
Of [spco] 0.000583608411078
Screening [hlca] 0.000583191761282
Physical activity [dora] 0.000582625057081
Comparison [acty] 0.000581851123026
secondary [neop] 0.000581497746569
Contribute [acty] 0.000581428057107
weeks [tmco] 0.000579951958487
Duration [tmco] 0.00057909519161
Various [irda] 0.000577871598553
Ethanol [orch] 0.000577329253933
Six [qnco] 0.000576923760228
Fatal [qlco] 0.00057631108365
Discharge [bdsu] 0.000575009801989
society [orgt] 0.000573478395983
Primary Care [hlca] 0.000571647633229
Cardiology [bmod] 0.000564530087503
Cost [qnco] 0.000563473713986
Therapies [topp] 0.000561879084316
Novel [tmco] 0.000561500509712
Complete [qlco] 0.00056141053164
hypertensive [fndg] 0.000560516248483
Concern [idcn] 0.000560022120652
recommendations [idcn] 0.000559367692397
APPEAR [qlco] 0.000556264922878
Oral [spco] 0.000555381550169
Ageing [orgf] 0.000552495987873
Obese [dsyn] 0.000552266022073
Life Style [socb] 0.000550605794333
Estrogens [horm, phsu, strd] 0.000549898747798
Affect [menp] 0.000548609785317
investigate [ftcn] 0.000547590976887
With [qlco] 0.000544360407474
Represent [acty] 0.000542145695538
criteria [inpr] 0.000542017458615
Late [tmco] 0.000540222815441
cardiovascular risk factor [dsyn] 0.00054009760815
deaths [orgf] 0.000539352234015
Multi [qnco] 0.000536194855637
Clinical Trials [resa] 0.000535708248723
reviewed [inpr] 0.000534443072751
Addition [ftcn] 0.000533805762218
Standard [qlco] 0.000533754699327
Measure [qnco] 0.000532276347392
Administration [ocac] 0.000531817315656
Status [qlco] 0.000529695136445
Died [orgf] 0.000529665074044
Magnetic Resonance Imaging [diap] 0.000529101007579
Inflammatory [ftcn] 0.000529080503136
mmHg [qnco] 0.000528427816265
Revealed [qlco] 0.000528108096581
Out [spco] 0.000526527481477
Interaction [ftcn] 0.000524493699376
Agent [chvf] 0.000523643583269
procedures [inpr] 0.000522317506745
Direct [qlco] 0.000521543103767
Presented [idcn] 0.000519926105556
Procedure [diap, topp] 0.00051980560017
Decade [qnco] 0.00051622520312
investigated [ftcn] 0.000515734942329
Damage [inpo] 0.000515234496264
Pre-operative [tmco] 0.000514953194693
Renal [bpoc] 0.000513098954789
Inflammation [patf] 0.000512641239015
Session [evnt] 0.000508488380477
Action [ftcn] 0.000508236690134
Comorbidity [idcn] 0.000508169143617
treating [topp] 0.000507282352708
Play [dora] 0.00050690441204
retrospective [resa] 0.000506901208493
Countries [geoa] 0.000506819583366
Ireland [geoa] 0.00050636149114
End [spco] 0.000506020992504
Renal dysfunction [fndg] 0.000500211581783
prospective [resa] 0.000499565417041
Questionnaire [inpr] 0.000499413505136
Currently [tmco] 0.000495965918766
Pulmonary arterial hypertension [dsyn] 0.00049538038873
Meta-Analysis [inpr] 0.000493108895636
Burden [idcn] 0.000491443983599
Initial [tmco] 0.000491206645295
Beta-Blockers [phsu] 0.00048926130839
Surgical [hlca] 0.000487728658859
Second [qnco] 0.000486817558872
Bias [idcn] 0.000485233477934
Knowledge [inpr] 0.000485227008858
Part [spco] 0.000484884406624
Sample [sbst] 0.000484861144328
prescribed [hlca] 0.00048464758707
paediatric [bmod] 0.000482900716013
Improving [qlco] 0.0004827271707
Ischaemic [ftcn] 0.000480541095805
World [popg] 0.000480525757293
If [qlco] 0.000480233966284
progression [patf] 0.000479727659179
Marker [clna] 0.000479117009085
PLAN [dsyn] 0.000478808449523
Guide [prog] 0.000477871684139
Dyslipidaemia [dsyn] 0.000477078630189
Ischaemic stroke [dsyn] 0.000477012371888
Age-Years [tmco] 0.000476400995079
topic1
P NOS [aapp, imft] 0.0125989784771
treatment [ftcn] 0.00976538969674
Study [mnob] 0.00664475317545
Group [idcn] 0.00629412944733
Women [popg] 0.0060011425132
Compared [acty] 0.00518039639708
Cardiovascular disease [dsyn] 0.00464193990487
Methods [inpr] 0.00463426013646
Trial [resa] 0.0043603334879
Conclusions [idcn] 0.00414377781736
Based [ftcn] 0.00397146934162
Mortality [qnco] 0.00383143402785
Increased [qnco] 0.0036840166876
Age [orga] 0.00361979753651
CARDIOVASCULAR [bdsy] 0.00314677520602
months [tmco] 0.00311337695232
Hypertension [dsyn] 0.00291079249791
therapy [ftcn] 0.00281878817147
treated [topp] 0.00280500734132
included [ftcn] 0.0026987805737
effects [qlco] 0.00249883856048
Management [ocac] 0.00244935434482
Including [ftcn] 0.00235791445983
radiotherapy [inpr] 0.00232159414537
participants [popg] 0.00230649630719
Cardiac [bpoc] 0.00226613702992
Stroke [dsyn] 0.00225701323609
Health [idcn] 0.00222443288779
Quality [qlco] 0.00212257772006
N NOS [aapp, imft] 0.00209882375995
Men [popg] 0.00207250223855
Efficacy [qlco] 0.00206639359708
Diabetes [dsyn] 0.00206326630831
Statins [orch, phsu] 0.00198510140043
Drug [phsu] 0.00192740839813
Range [qnco] 0.00187206508835
Specific [qlco] 0.00187133934789
Old [tmco] 0.00182536348772
risk factors [qnco] 0.00180761116958
Survival [acty] 0.00180330499475
Surgery [bmod] 0.00178916246534
High Risk [qlco] 0.00178618724401
Breast Cancer [neop] 0.00176206429609
Performed [ftcn] 0.00169022019981
Venous malformation [anab] 0.0016765177194
Heart failure [dsyn] 0.00167262933078
Association [menp] 0.00166337662514
Heart [bpoc] 0.0016385318371
Odds Ratio [qnco] 0.00161945161635
Blood Pressure [orgf] 0.00159173667576
Reserve [acty] 0.00156069605483
Cases [ftcn] 0.00153949095874
reduction [npop] 0.00153125323925
Suggest [idcn] 0.00151741439255
Large [qnco] 0.00151674487862
Observed [ftcn] 0.00150857550054
Evaluate [ftcn] 0.00150503802106
Dose [qnco] 0.00149802073936
PREVENT [phsu] 0.00149378838881
IMPACT [gngm] 0.00148696909588
Purpose [ftcn] 0.00148043589761
Present [qnco] 0.00147137504402
Reduced [qlco] 0.00145982991621
Sclerotherapy [topp] 0.00144896430731
Assessed [acty] 0.00144311356929
Objective [inpr] 0.00142728600212
Children [aggp] 0.00142629288221
Levels [qlco] 0.00142181705645
Hazard Ratio [qnco] 0.00139891226174
baseline [bodm] 0.00139667006523
Prevention [topp] 0.00135844878486
Complications [patf] 0.00133719312091
Evaluated [ftcn] 0.00133634333733
postmenopausal [tmco] 0.00132239686667
search [inpr] 0.00131835789938
C-reactive protein [aapp, imft] 0.00131399665244
Primary [qlco] 0.00128451921941
cardiovascular events [fndg] 0.0012785784211
effective [qlco] 0.00127383502124
Reported [inpr] 0.00127304717117
Receive [qlco] 0.00125903729277
Hormone replacement therapy [topp] 0.00125562895636
Atrial Fibrillation [patf] 0.00125398577851
Induced [ftcn] 0.00124727911653
Diagnosed [fndg] 0.00124387371517
Make [ftcn] 0.00122565797568
placebo [topp] 0.00122249141854
Conduct [inbe] 0.00121615282411
Long [qlco] 0.00121184387517
Safety [hcpp] 0.00121002661403
Benefit [qnco] 0.00120636101533
Score [qnco] 0.00120146989026
Myocardial Infarction [dsyn] 0.00119641406334
Comorbidities [idcn] 0.00119428670399
Design [acty] 0.00116563799114
People [popg] 0.00116176094413
Received [qlco] 0.00115888774319
practice [menp] 0.00115387017111
Need [qlco] 0.0011506586789
findings [ftcn] 0.00114422244933
Authors [prog] 0.00114186837028
Effectiveness [qlco] 0.0011378096333
condition [dsyn] 0.00113689490085
Adjusted [ftcn] 0.00113360115889
experience [menp] 0.00112768825983
Identified [qlco] 0.00111477888717
Life [idcn] 0.00110623653585
Approach [spco] 0.00110084069934
coronary heart disease [dsyn] 0.00109992618082
Metabolic syndrome [dsyn] 0.00109616721841
Irradiation [npop] 0.00108628436782
Current [tmco] 0.00107582966446
setting [ftcn] 0.00106876775906
Subject [grup] 0.00106811510679
Available [ftcn] 0.0010529015562
Therapeutic [topp] 0.00103944065952
Guidelines [inpr] 0.00103638804667
Appropriate [qlco] 0.00103285123621
Chronic kidney disease [dsyn] 0.0010277051717
Limited [ftcn] 0.00100360607691
Main [qlco] 0.00100300524218
Evaluation [ftcn] 0.000999653335071
Care [acty] 0.000997252094583
Confidence Intervals [qnco] 0.000988313153256
History [ocdi] 0.000986081834527
Heart disease [dsyn] 0.000982245722278
GY [geoa] 0.000972621531599
function [phsf] 0.00096769606667
symptoms [ftcn] 0.000963202336884
Controlled [ftcn] 0.000960984017769
Survivors [podg] 0.000953570737204
Decreased [qnco] 0.00095160536273
Characteristics [qlco] 0.000946893539335
strategies [menp] 0.000944520763837
acute [tmco] 0.000942578278822
Mechanisms [ftcn] 0.000936363477864
Aged [orga] 0.000932446645852
Obesity [dsyn] 0.000924973381268
Parameters [fndg] 0.000917075626076
Young [tmco] 0.000910057774123
lesions [fndg] 0.000909269754084
Profile [lbpr] 0.000903954082831
Examined [fndg] 0.000899680304397
Several [qnco] 0.000897200622349
interventions [hlca] 0.000894686318052
Update [tmco] 0.000894244980194
Searched [acty] 0.000894025380665
weeks [tmco] 0.000893206409526
Medical [ftcn] 0.000890620478424
vascular [bpoc] 0.000886154555774
Acute myocardial infarction [dsyn] 0.000884532915106
Radiation [npop] 0.000884473140156
objectives [inpr] 0.000879469415973
Improvement [cnce] 0.000877234113391
Elderly [popg] 0.000876056298787
investigate [ftcn] 0.00087555322394
Following [tmco] 0.000875384340875
coronary artery disease [dsyn] 0.000875182011743
Response [orga] 0.000874638908359
Measured [qlco] 0.000867878349592
Prognostic Factor [clna] 0.000861683887379
Functional [ftcn] 0.000859426159045
Complex [qlco] 0.00085921787052
Independent [idcn] 0.000853498893155
Severe [qlco] 0.000848238182685
Defined [cnce] 0.000846737045795
Cost Effectiveness [qnco] 0.000845765032085
ischaemic heart disease [dsyn] 0.000843451568665
randomized [resa] 0.000841942777168
Female [fndg] 0.000841450637522
Published [ocac] 0.000840475741576
Statin [orch, phsu] 0.000829606089691
Small [qnco] 0.000818942318577
Adults [aggp] 0.000815321407436
Reducing [qlco] 0.00081418261824
Atherosclerosis [dsyn] 0.00081301571296
Estimated [qnco] 0.000807501745387
Ratio [qnco] 0.000807017545813
System [ftcn] 0.000804472048675
Physicians [prog] 0.000801346468654
Established [qlco] 0.000798811274198
Multiple [qnco] 0.000794494054496
days [tmco] 0.000792591829329
Vascular Malformations [anab] 0.000790746417683
Benefits [qnco] 0.000788385979754
Known [qlco] 0.000786940723974
Medication [phsu] 0.000785877343981
Combination [qlco] 0.000782966589419
Increasing [ftcn] 0.000781670295339
Article [inpr] 0.00077877422054
Events [evnt] 0.000775928305332
Adherence [ftcn] 0.000775353771711
Central [spco] 0.00077313655948
Single [popg] 0.000773076445641
Target [ftcn] 0.000772449170314
Hospital [hcro, mnob] 0.000770501800084
Likely [qlco] 0.000763624748799
Diseases [dsyn] 0.000759098809933
Index [inpr] 0.000755456428949
Risks [qlco] 0.000753875833172
Comparison [acty] 0.000753105335855
chronic [tmco] 0.000752626533641
Body Mass Index [diap] 0.000751141253627
Marker [clna] 0.000748193492056
Alone [qnco] 0.000747556150266
Six [qnco] 0.000746872100889
Understanding [menp] 0.000743143316471
Novel [tmco] 0.00074202360577
Secondary Prevention [topp] 0.000741647113587
Literature [inpr] 0.00074136756118
Previous [tmco] 0.000739211069348
Needed [qlco] 0.000733847036812
Sex [orgf] 0.000731316907029
Address [inpr] 0.000729576530588
Plasma [bdsu] 0.000718590829809
Addition [ftcn] 0.000717004796177
Lipid [lipd] 0.000714341422868
Information [idcn] 0.000713513857766
rats [mamm] 0.000710697306146
Cardiovascular Diseases [dsyn] 0.000708111134699
Drug Therapy [topp] 0.000706945276073
Standard [qlco] 0.000705551059249
Various [irda] 0.000704221197034
Five [qnco] 0.000701455755644
Drugs [phsu] 0.000700787534649
intervention [hlca] 0.000699242530195
Issue [fndg] 0.000694187239227
Select [acty] 0.000686814410562
Burden [idcn] 0.000682207534807
LTD [ortf] 0.000681872931548
Estrogen [horm, phsu, strd] 0.00068144965577
Well [qlco] 0.000680559887301
Exercise [dora] 0.000678807915022
Adult [aggp] 0.000678702569282
Diabetes Mellitus [dsyn] 0.000678360385826
Medications [phsu] 0.000675477079961
Occurred [acty] 0.000672240046904
randomized controlled trials [inpr, resa] 0.000667828355372
Future [tmco] 0.00066742937621
Relationship [qlco] 0.000663408581698
Often [tmco] 0.000662427194341
Morbidity [qnco] 0.000662166698753
Postoperative [tmco] 0.000651563401519
Relevant [qlco] 0.000649928416928
APPEAR [qlco] 0.000649478695426
national [inpr] 0.000648990873003
Average [qnco] 0.000648722481649
Focus [spco] 0.000645337306031
Improved [qlco] 0.000642445704988
Associations [menp] 0.000642392265877
Moderate [qlco] 0.000641994756876
Few [qnco] 0.00064173545603
Breast [bpoc] 0.000640090166183
Database [inpr] 0.000639570599022
Tool [mnob] 0.000638874309124
Screening [hlca] 0.000638056627809
Treatments [topp] 0.000637513384314
coronary [bpoc] 0.000636438129918
deaths [orgf] 0.000634605776033
Last [qlco] 0.000634288197773
Beta-Blockers [phsu] 0.000634004627801
Presented [idcn] 0.000632625109317
Imaging [diap] 0.000632412830292
Represent [acty] 0.000629151720134
Decrease [qlco] 0.000624641680542
Additional [ftcn] 0.000624417700802
Help [socb] 0.000623939543698
Optimal [qlco] 0.000623883133212
Inflammation [patf] 0.000622744423666
cardiovascular risk factor [dsyn] 0.000621206862793
Dyslipidaemia [dsyn] 0.000620752520155
Status [qlco] 0.000619734099379
Meta-Analysis [inpr] 0.000619365478394
investigated [ftcn] 0.000617530565731
M NOS [aapp, imft] 0.000614390864461
Relative [famg] 0.00061332092054
Countries [geoa] 0.000611839295926
free [ftcn] 0.000611091562792
considered [idcn] 0.000610152953118
Take [hlca] 0.000607137098786
Prostate Cancer [neop] 0.000605435739804
Combined [qlco] 0.000599550730861
Life Style [socb] 0.00059905823886
Affect [menp] 0.0005987503105
Ischaemic [ftcn] 0.000596276640155
Surgical [hlca] 0.000593416812523
Symptomatic [ftcn] 0.000592627789059
Center [spco] 0.0005911746919
Out [spco] 0.000589514145492
patient care [hlca] 0.000589512440089
Stage [tmco] 0.000589442099746
Leading [tmco] 0.000589044050488
GIVEN [cnce] 0.000588860991893
heart rate [clna] 0.000588798829933
Questionnaire [inpr] 0.000584061109876
Androgen Deprivation Therapy [topp] 0.000584055530102
Knowledge [inpr] 0.000580245116576
Normal [qlco] 0.000579161784685
Proportion [qnco] 0.000578871874055
Physical activity [dora] 0.00057754751583
Seen [qlco] 0.000577281022214
secondary [neop] 0.000576372615242
Local [spco] 0.000575990533984
procedures [inpr] 0.000573795894811
reviewed [inpr] 0.000573717581388
Congenital heart disease [cgab, dsyn] 0.000572854547537
Chemotherapy [topp] 0.00057232499337
recommendations [idcn] 0.000571553931303
Primary Care [hlca] 0.000570716149921
Bleeding [patf] 0.000569049344395
Died [orgf] 0.000568294698009
Menopause [phsf] 0.000567177065327
Obtained [ftcn] 0.00056507000683
Obese [dsyn] 0.000564529325593
Data Collection [resa] 0.000563481932267
Form [qlco] 0.00056050911381
Assessment [hlca] 0.000560410314408
Cells [cell] 0.000558269347847
Agent [chvf] 0.000557963192747
Report [inpr] 0.000557760483878
Provided [acty] 0.000556380307993
Action [ftcn] 0.000555021974117
Clinical Trials [resa] 0.000554695695556
Arterial [bpoc] 0.000551905290873
Venous Thromboembolism [patf] 0.000550514978692
prospective [resa] 0.000549685134092
Prescription [hlca] 0.000544866707282
Discharge [bdsu] 0.000544595271986
With [qlco] 0.000543763448843
Head [blor] 0.000543693804735
Cardiology [bmod] 0.00054356859712
adverse events [fndg] 0.000540781190968
Depression [mobd] 0.00053778576786
side effects [ftcn] 0.000535960231321
Recently [tmco] 0.00053539334575
Aspirin [orch, phsu] 0.000534519813739
Ageing [orgf] 0.000532862206616
In [qnco] 0.000532123326752
activity [dora] 0.000531234415965
Acute Coronary Syndrome [dsyn] 0.000530956788537
Post [tmco] 0.000529316667382
Dialysis [npop] 0.000529251698096
Program [cnce] 0.000529129699035
strategy [menp] 0.00052846615788
criteria [inpr] 0.000526537639664
Lung Cancer [neop] 0.000525765835697
Smoking [inbe] 0.000524833411868
Magnetic Resonance Imaging [diap] 0.000524069042971
lack [qlco] 0.000522613966789
Recommended [idcn] 0.000522537351005
Values [qlco] 0.000522385611159
If [qlco] 0.000522185298561
Measures [qnco] 0.000520908141099
Structural [spco] 0.000520354278217
Stable [qlco] 0.000516726241015
???lead [elii, hops] 0.000510398397441
statistically significant [qnco] 0.000506873759252
Initial [tmco] 0.000505545851508
Hospitalization [hlca] 0.00050535751135
Guide [prog] 0.000505070106752
Bias [idcn] 0.000503642181704
Play [dora] 0.000503488139672
Oral [spco] 0.000501216152071
Patterns [spco] 0.00050026950938
surveillance [ftcn] 0.000497960367184
Therapies [topp] 0.00049646472435
Renal dysfunction [fndg] 0.000496016940601
Technique [ftcn] 0.000495636309449
Gender [orga] 0.00049461895877
radiation therapy [inpr] 0.000494594676723
Support [medd] 0.000494228365024
Revealed [qlco] 0.000492937681299
hypertensive [fndg] 0.000488409955991
Diagnostic [fndg] 0.000488340010967
Control Group [grup] 0.000485730067419
variables [qlco] 0.000485602378233
Metabolic [ftcn] 0.000485277125024
Severity [qlco] 0.00048453776536
prescribed [hlca] 0.00048347052195
Cost [qnco] 0.000482562187706
Estrogens [horm, phsu, strd] 0.000481477639286
peripheral arterial disease [dsyn] 0.00048009665437
Interaction [ftcn] 0.000477806932419
retrospective [resa] 0.000476926042025
Extracted [topp] 0.000476124074719
size [spco] 0.000473905993666
Systolic blood pressure [clna] 0.000473482867168
Direct [qlco] 0.000473459653036
Decade [qnco] 0.000472240903202
Ischaemic stroke [dsyn] 0.000471733555124
Diet [food] 0.000470548159662
Process [bpoc] 0.000468362375162
lowering [spco] 0.000465849203513
Echocardiography [diap] 0.000464988331787
Duration [tmco] 0.000463326639723
Critical [qlco] 0.000463200180502
Reporting [hlca] 0.000462427895043
Currently [tmco] 0.000461998738715
Procedure [diap, topp] 0.000461584991824
Length [qnco] 0.000461089581497
topic2
treatment [ftcn] 0.0095089955522
P NOS [aapp, imft] 0.00894745769923
Women [popg] 0.00753473032164
Study [mnob] 0.0072695891885
Group [idcn] 0.00703655796544
Cardiovascular disease [dsyn] 0.00667165391436
Mortality [qnco] 0.00490346207162
Increased [qnco] 0.00426051500398
Methods [inpr] 0.00416630625975
Compared [acty] 0.00388848600821
CARDIOVASCULAR [bdsy] 0.00377846772669
Trial [resa] 0.00372312744332
Age [orga] 0.00351029051214
Based [ftcn] 0.00309847888447
Hypertension [dsyn] 0.00306225879677
Conclusions [idcn] 0.00298565985048
effects [qlco] 0.00295598872836
Stroke [dsyn] 0.00278540251385
treated [topp] 0.00250894290308
Men [popg] 0.00245708853143
included [ftcn] 0.00245034831427
therapy [ftcn] 0.00240712977722
Management [ocac] 0.0023323135936
Diabetes [dsyn] 0.00232861019358
Including [ftcn] 0.00222961757562
months [tmco] 0.00217142807933
Old [tmco] 0.00216265054283
Survival [acty] 0.00208922425923
radiotherapy [inpr] 0.00205181529279
Present [qnco] 0.00202763520964
Care [acty] 0.0019419386001
Prevention [topp] 0.00193735734444
N NOS [aapp, imft] 0.00193376088677
Surgery [bmod] 0.00193276583227
Complications [patf] 0.00187025830998
Cardiac [bpoc] 0.00186944934114
Efficacy [qlco] 0.00184281857295
Reduced [qlco] 0.00179855163391
Heart [bpoc] 0.00178128133439
Quality [qlco] 0.00178008349673
Observed [ftcn] 0.0017491390275
risk factors [qnco] 0.00173289112967
participants [popg] 0.00172666101195
High Risk [qlco] 0.00171744301435
Reserve [acty] 0.00169642687132
Induced [ftcn] 0.00168754597088
Primary [qlco] 0.00168740405675
Breast Cancer [neop] 0.00162240507056
Target [ftcn] 0.001613845486
interventions [hlca] 0.00159778381505
Evaluate [ftcn] 0.00158622106242
Assessed [acty] 0.00155693769473
Main [qlco] 0.00155474105136
Heart failure [dsyn] 0.00155057607371
Drug [phsu] 0.00154861196489
search [inpr] 0.00154826959378
Health [idcn] 0.00154327798449
Association [menp] 0.00152216144796
Suggest [idcn] 0.00152141847801
Specific [qlco] 0.00151584473432
Hormone replacement therapy [topp] 0.0015074762228
Odds Ratio [qnco] 0.00150144585408
Identified [qlco] 0.00149010353779
Levels [qlco] 0.00147114801049
Objective [inpr] 0.00145956840609
Improved [qlco] 0.00145708584809
Venous malformation [anab] 0.00144610656922
Purpose [ftcn] 0.00143484211725
Range [qnco] 0.00142712973544
Received [qlco] 0.00142655135426
Therapeutic [topp] 0.0014255140632
reduction [npop] 0.00141724295347
Performed [ftcn] 0.00139986124523
Statins [orch, phsu] 0.0013988522023
coronary heart disease [dsyn] 0.00138997714419
effective [qlco] 0.00136392818153
PREVENT [phsu] 0.00136120421934
Blood Pressure [orgf] 0.00134823904097
baseline [bodm] 0.00134207885654
placebo [topp] 0.00133881931056
Approach [spco] 0.0013264317063
condition [dsyn] 0.0013261778302
postmenopausal [tmco] 0.00131617316235
Medications [phsu] 0.00131430565553
Authors [prog] 0.0013009109387
Children [aggp] 0.00129490414161
Prognostic Factor [clna] 0.00128146174616
Life [idcn] 0.00127798940536
Atherosclerosis [dsyn] 0.00124985083694
Several [qnco] 0.0012477722643
Evaluated [ftcn] 0.00124653534725
Myocardial Infarction [dsyn] 0.00123246784792
Current [tmco] 0.0012260578879
Conduct [inbe] 0.0012260021841
Dose [qnco] 0.00121877062394
practice [menp] 0.00121523217516
Hazard Ratio [qnco] 0.00120755720306
Cases [ftcn] 0.00119226754007
Information [idcn] 0.00119127131219
Often [tmco] 0.00117063675024
Estimated [qnco] 0.00116814875002
Sclerotherapy [topp] 0.00116735840583
Subject [grup] 0.00115212922303
Need [qlco] 0.00114124351605
objectives [inpr] 0.00113615891564
Improvement [cnce] 0.00112465147875
intervention [hlca] 0.00111405300718
IMPACT [gngm] 0.00111315962797
Effectiveness [qlco] 0.00111292880137
Statin [orch, phsu] 0.00111192836911
Large [qnco] 0.00110968088643
Score [qnco] 0.00110579638853
Adjusted [ftcn] 0.00108095999561
People [popg] 0.00106352131068
Reported [inpr] 0.00106274852053
Safety [hcpp] 0.00105372431963
Confidence Intervals [qnco] 0.00104705903251
Design [acty] 0.00104002622606
cardiovascular events [fndg] 0.00103939110634
Radiation [npop] 0.00103311585524
days [tmco] 0.00100831286272
Benefit [qnco] 0.00100651615838
Increasing [ftcn] 0.00100210024538
Medical [ftcn] 0.000997149347797
C-reactive protein [aapp, imft] 0.000996313474871
Following [tmco] 0.000989378407048
Additional [ftcn] 0.000985875366649
Receive [qlco] 0.000985574051156
Guidelines [inpr] 0.000981012870799
lesions [fndg] 0.00096871435926
Measured [qlco] 0.000961677902961
Medication [phsu] 0.000945952766636
Heart disease [dsyn] 0.00094107253032
Searched [acty] 0.000932150943395
Make [ftcn] 0.000931097131795
Normal [qlco] 0.000930930961812
Comorbidities [idcn] 0.000930439404386
Well [qlco] 0.000925186628808
Future [tmco] 0.000914382953176
Alone [qnco] 0.000912865468408
findings [ftcn] 0.000907284065851
experience [menp] 0.000904852189606
Aged [orga] 0.000903376106278
Hospital [hcro, mnob] 0.000901869355663
Needed [qlco] 0.000893873124831
Irradiation [npop] 0.000891172715722
Discharge [bdsu] 0.000888908494608
GY [geoa] 0.000882063127629
coronary artery disease [dsyn] 0.000881346476946
symptoms [ftcn] 0.000877752109105
Adults [aggp] 0.000876908798236
vascular [bpoc] 0.000876737998584
Drugs [phsu] 0.000874197176578
Article [inpr] 0.000871770623381
acute [tmco] 0.000868813494994
setting [ftcn] 0.000865790201884
Aspirin [orch, phsu] 0.000857643061094
Physical activity [dora] 0.000857086070396
Likely [qlco] 0.000855657486802
considered [idcn] 0.000855083007765
Oral [spco] 0.000846055331661
Independent [idcn] 0.000845705989138
Last [qlco] 0.000841986725088
Six [qnco] 0.000841139610048
System [ftcn] 0.000838377069726
Ratio [qnco] 0.000836962345263
Multiple [qnco] 0.000836390937753
Published [ocac] 0.000836377427697
Complex [qlco] 0.000835334568039
Burden [idcn] 0.000834747321554
Benefits [qnco] 0.000834247929599
Combination [qlco] 0.000831625696372
In [qnco] 0.000830874001393
Combined [qlco] 0.000830136205631
Atrial Fibrillation [patf] 0.000826555764662
Known [qlco] 0.000825028477611
Decreased [qnco] 0.000824752645445
Female [fndg] 0.000820057185845
Diagnosed [fndg] 0.00081866227132
Breast [bpoc] 0.0008157303906
Androgen Deprivation Therapy [topp] 0.000810161534149
Literature [inpr] 0.000809778170585
Index [inpr] 0.000807425942383
Parameters [fndg] 0.000806818198222
Young [tmco] 0.000800371042945
randomized [resa] 0.00079881030062
Sex [orgf] 0.00079759339672
Diseases [dsyn] 0.000795759183965
Single [popg] 0.000795345390187
Survivors [podg] 0.000785201836213
Status [qlco] 0.000785046727358
Recommended [idcn] 0.000784043985341
rats [mamm] 0.000778629778463
function [phsf] 0.000778219058609
strategies [menp] 0.000774965532745
Controlled [ftcn] 0.000772115550161
Average [qnco] 0.000764342114857
weeks [tmco] 0.000764206565614
Evaluation [ftcn] 0.000763866953247
Elderly [popg] 0.000763819497532
Estrogen [horm, phsu, strd] 0.00076050261449
Adherence [ftcn] 0.00076024988056
Long [qlco] 0.000757781054169
Adult [aggp] 0.000746522700951
investigated [ftcn] 0.00074461211411
History [ocdi] 0.000744482203267
ischaemic heart disease [dsyn] 0.000743140007566
Small [qnco] 0.000741191848402
Update [tmco] 0.000738882699233
Events [evnt] 0.000738674939855
Examined [fndg] 0.000736898269817
Drug Therapy [topp] 0.000736784673405
Extracted [topp] 0.000733459772822
Support [medd] 0.000726686431032
Severe [qlco] 0.000725080301531
Body Mass Index [diap] 0.000724115909696
Imaging [diap] 0.000724088194434
Morbidity [qnco] 0.000723473085793
Prostate Cancer [neop] 0.000722477259611
Metabolic syndrome [dsyn] 0.000721995915188
Defined [cnce] 0.00072171221081
Hospitalization [hlca] 0.000721072214992
Characteristics [qlco] 0.000720048904449
Life Style [socb] 0.000719348744459
Available [ftcn] 0.000717568124173
national [inpr] 0.000716405601716
Five [qnco] 0.000715903092176
Select [acty] 0.00071559897964
Risks [qlco] 0.000713576379313
strategy [menp] 0.000712708588626
Appropriate [qlco] 0.000712210134396
Established [qlco] 0.000708247236731
M NOS [aapp, imft] 0.000707280676016
Comparison [acty] 0.000706571172545
Area [geoa] 0.000702976701202
patient care [hlca] 0.000702401134863
Decrease [qlco] 0.000697232809354
Central [spco] 0.000696515204244
Profile [lbpr] 0.000680989412112
Marker [clna] 0.000680332923014
mmHg [qnco] 0.000679517346785
Cost Effectiveness [qnco] 0.000679097925596
investigate [ftcn] 0.000673334401732
Post [tmco] 0.000671620418326
adverse events [fndg] 0.000666289892493
Obesity [dsyn] 0.000664357046986
Take [hlca] 0.000662878365289
Relevant [qlco] 0.000662495387654
Limited [ftcn] 0.000659797207757
Postoperative [tmco] 0.000653194035546
cardiovascular risk factor [dsyn] 0.000650901609323
Chemotherapy [topp] 0.000645936905373
Relationship [qlco] 0.000645850500474
prognostic [inpr] 0.000643711757129
Diabetes Mellitus [dsyn] 0.000643037067134
Lipid [lipd] 0.000642269936738
Novel [tmco] 0.000641036616127
???lead [elii, hops] 0.000640007047759
Treatments [topp] 0.000638051640429
Ischaemic [ftcn] 0.000636285909593
Standard [qlco] 0.00063583740106
GIVEN [cnce] 0.000633384694945
Late [tmco] 0.000631030827786
Mechanisms [ftcn] 0.000630034996016
prospective [resa] 0.000624551510422
society [orgt] 0.000624047712642
Presented [idcn] 0.000623982268677
Proportion [qnco] 0.000621756710718
Functional [ftcn] 0.000621060307682
secondary [neop] 0.000615361224112
Address [inpr] 0.000614064349655
Understanding [menp] 0.000614046071616
Countries [geoa] 0.000612068558703
Assessment [hlca] 0.000611409986793
Cost [qnco] 0.000610801540047
Vascular Malformations [anab] 0.000609521002826
free [ftcn] 0.000609402150802
Menopause [phsf] 0.000608524052811
LTD [ortf] 0.000606721286328
Physicians [prog] 0.000604371610486
Decade [qnco] 0.000603058306155
Cells [cell] 0.000601305132209
Program [cnce] 0.000601175967629
American [popg] 0.000600510428374
Cardiovascular Diseases [dsyn] 0.000599358982948
Moderate [qlco] 0.000598992822936
Smoking [inbe] 0.00059863965919
Clinical Trials [resa] 0.000596033842472
Review, Systematic [inpr] 0.000595318394952
Fatal [qlco] 0.000594994006903
Administration [ocac] 0.000594217284279
randomized controlled trials [inpr, resa] 0.000593699126746
Stress [fndg] 0.000593630877533
Affect [menp] 0.000592444718536
Damage [inpo] 0.000591637938402
Meta-Analysis [inpr] 0.00059098810824
Revealed [qlco] 0.000587480426026
Issue [fndg] 0.000585632359691
Agent [chvf] 0.000585120192957
Chronic kidney disease [dsyn] 0.000582490557217
Associations [menp] 0.000581605113937
Occurred [acty] 0.000580590070379
Acute myocardial infarction [dsyn] 0.000578403020896
coronary [bpoc] 0.000578301624605
Cardiology [bmod] 0.000577006185306
APPEAR [qlco] 0.0005766073977
Indicated [fndg] 0.000576287624306
Optimal [qlco] 0.00057563210955
Previous [tmco] 0.000572542304787
Bias [idcn] 0.000572229730236
Guide [prog] 0.000570657868017
Primary Care [hlca] 0.000569583754126
chronic [tmco] 0.000568760615878
Regression [patf] 0.000568181691332
side effects [ftcn] 0.000567319267503
Therapies [topp] 0.000567183984598
Estrogens [horm, phsu, strd] 0.000560500541541
Required [ftcn] 0.000555626782097
Reducing [qlco] 0.000553122541183
procedures [inpr] 0.000549125456182
Ageing [orgf] 0.000547729400071
recommendations [idcn] 0.000545958112615
Derived [qlco] 0.00054179109386
Arterial [bpoc] 0.000541413255978
Various [irda] 0.000540573868524
hypertensive [fndg] 0.000539214950917
heart rate [clna] 0.000537786842377
Report [inpr] 0.000537005072501
Bleeding [patf] 0.000536570067244
Response [orga] 0.000536020353681
Leading [tmco] 0.000535934749181
Polypharmacy [fndg] 0.000535046920194
paediatric [bmod] 0.000532544789817
Ethanol [orch] 0.000531390637828
Venous Thromboembolism [patf] 0.0005296369193
criteria [inpr] 0.000526153144135
Concern [idcn] 0.000524831443148
malformations [ftcn] 0.000522940877079
Stage [tmco] 0.000521348688922
Value [qnco] 0.000519244590759
activity [dora] 0.000518078546956
prescribed [hlca] 0.000517453520358
Interaction [ftcn] 0.000516064808321
Help [socb] 0.000515186006533
Flow [npop] 0.00051461504359
Addition [ftcn] 0.000513662191909
Colorectal Cancer [neop] 0.000512991286318
deaths [orgf] 0.000512070852779
Head [blor] 0.000511101945668
Diet [food] 0.00051042517562
Percutaneous Coronary Intervention [topp] 0.000510206602362
Magnetic Resonance Imaging [diap] 0.000509521076229
Percutaneous [spco] 0.000508489307813
Recently [tmco] 0.000507220705163
computed tomography [diap] 0.000506511067884
Values [qlco] 0.000505570773462
Lung Cancer [neop] 0.000503899685074
Depression [mobd] 0.000502048480247
Ischaemic stroke [dsyn] 0.000502001290202
Provided [acty] 0.000501662002327
reviewed [inpr] 0.000501635183578
Rheumatoid Arthritis [dsyn] 0.000501203809662
lowering [spco] 0.000498062450296
Calculated [ftcn] 0.000496884917016
Pulmonary Disease, Chronic Obstructive [dsyn] 0.000495895765645
Measure [qnco] 0.000495118241668
occurrence [ftcn] 0.000493846895646
Direct [qlco] 0.000493638367881
Dependent [qlco] 0.000492585306746
DEVICES [medd] 0.000490795604609
Now [tmco] 0.000490365636596
Died [orgf] 0.000490295658649
Classification [clas] 0.000489964054965
radiation therapy [inpr] 0.000489955086868
Concentrations [menp] 0.000489621801641
Obtained [ftcn] 0.000489039054838
Congenital heart disease [cgab, dsyn] 0.000488364356695
Duration [tmco] 0.000488088075403
Length [qnco] 0.000486717521021
Exercise [dora] 0.000486640424996
Total Cholesterol [lbpr] 0.000486116941145
Metabolic [ftcn] 0.000485267758989
Pregnancy [orgf] 0.000484548087755
Injury [inpo] 0.000484343280367
Test [lbpr] 0.000483062758129
Onset [qlco] 0.000483004037522
Link [inpr] 0.000482781720174
Low Risk [fndg] 0.000481805187986
Renal [bpoc] 0.000481084436766
Antihypertensive [phsu] 0.000478102983647
Action [ftcn] 0.000477793917627
Challenge [clna] 0.000477393383551
Knowledge [inpr] 0.00047616747159
Pain [sosy] 0.000474424203157
Initiation [menp] 0.000473619476136
Obese [dsyn] 0.000473510374812
Subsequent [tmco] 0.000472263848088
Secondary Prevention [topp] 0.00047217847184
Relative [famg] 0.000471775187607
Pre-operative [tmco] 0.000471708711993
topic3
P NOS [aapp, imft] 0.00924884646336
Study [mnob] 0.00765188409747
treatment [ftcn] 0.00684853071883
Women [popg] 0.00671679422399
Mortality [qnco] 0.00610886664259
Group [idcn] 0.00576893351999
Age [orga] 0.00560640013681
Increased [qnco] 0.00491564823388
Cardiovascular disease [dsyn] 0.00399232036539
Hypertension [dsyn] 0.00338307347548
Compared [acty] 0.00332575881768
Trial [resa] 0.00330619795524
Methods [inpr] 0.00325516745042
CARDIOVASCULAR [bdsy] 0.00322384825109
Based [ftcn] 0.003089852293
included [ftcn] 0.00306192107969
therapy [ftcn] 0.00293616539971
Conclusions [idcn] 0.00273410753483
effects [qlco] 0.00264751284835
Including [ftcn] 0.00244838626041
Stroke [dsyn] 0.00233295327075
Quality [qlco] 0.00227191069156
radiotherapy [inpr] 0.00223347107132
Efficacy [qlco] 0.00215113844912
Evaluate [ftcn] 0.0020986864301
Specific [qlco] 0.00209750579051
Survival [acty] 0.0020680780428
Prevention [topp] 0.00204216113395
Health [idcn] 0.00202236042348
Cardiac [bpoc] 0.00198352134376
Cases [ftcn] 0.00197694424474
N NOS [aapp, imft] 0.0019756708817
Observed [ftcn] 0.00194205635222
Association [menp] 0.00192380972112
Men [popg] 0.00182965395212
Diabetes [dsyn] 0.00182472892581
participants [popg] 0.00181575408416
Old [tmco] 0.00180832063417
Management [ocac] 0.00179995741072
Odds Ratio [qnco] 0.00173155970206
Heart failure [dsyn] 0.00172270467557
treated [topp] 0.0016997998766
Heart [bpoc] 0.00169161450306
Levels [qlco] 0.00167769750882
Available [ftcn] 0.0016719449057
Dose [qnco] 0.00165538382628
months [tmco] 0.00163915351951
condition [dsyn] 0.00162014556424
Performed [ftcn] 0.00161446765756
Blood Pressure [orgf] 0.00160819009475
Received [qlco] 0.00158231032268
Design [acty] 0.00157790249853
Range [qnco] 0.00156455171849
reduction [npop] 0.00156376280816
Identified [qlco] 0.00156000565543
Statins [orch, phsu] 0.00154400233765
Reduced [qlco] 0.00153112597478
High Risk [qlco] 0.00153077447311
IMPACT [gngm] 0.00152030041915
Reserve [acty] 0.00150246138095
Reported [inpr] 0.00150125569636
Suggest [idcn] 0.00148030073127
Present [qnco] 0.0014776442453
effective [qlco] 0.00145196809672
Myocardial Infarction [dsyn] 0.00142340626667
Hazard Ratio [qnco] 0.00141246698616
Surgery [bmod] 0.00140983432203
Sclerotherapy [topp] 0.00139801815028
Adjusted [ftcn] 0.00137680071789
risk factors [qnco] 0.00136965321974
Life [idcn] 0.00134508825272
Hormone replacement therapy [topp] 0.00134059136553
coronary heart disease [dsyn] 0.00132239962589
baseline [bodm] 0.00132186064689
Purpose [ftcn] 0.00131599152738
Survivors [podg] 0.00131362307269
Prognostic Factor [clna] 0.00131040476902
Atrial Fibrillation [patf] 0.00130476432875
Need [qlco] 0.00130100950973
considered [idcn] 0.00129655625861
Primary [qlco] 0.00128156644171
Published [ocac] 0.00126023760225
Induced [ftcn] 0.00125996349876
Complications [patf] 0.00125132796814
Care [acty] 0.00124167880707
Main [qlco] 0.00123074744441
Statin [orch, phsu] 0.00122515031465
Breast Cancer [neop] 0.00122458321403
Subject [grup] 0.00122145434291
Guidelines [inpr] 0.00121639863282
postmenopausal [tmco] 0.0012152624599
Therapeutic [topp] 0.00121081681085
Authors [prog] 0.00120874227398
Children [aggp] 0.00120754351584
Appropriate [qlco] 0.00119751025056
Approach [spco] 0.00119708946443
Several [qnco] 0.00117810070102
interventions [hlca] 0.00115322275345
Diagnosed [fndg] 0.00114785355986
objectives [inpr] 0.00114743461546
Current [tmco] 0.00114577919892
Young [tmco] 0.00113689578534
Assessed [acty] 0.00113592836949
Evaluated [ftcn] 0.00113307336832
C-reactive protein [aapp, imft] 0.00112727430724
Objective [inpr] 0.0011221631811
Additional [ftcn] 0.0011160346664
Following [tmco] 0.00111554287799
Events [evnt] 0.00111542545116
Venous malformation [anab] 0.00111042439241
Receive [qlco] 0.0011084648983
Improved [qlco] 0.00110822769809
Estimated [qnco] 0.00110692881986
Target [ftcn] 0.00110496015302
Drugs [phsu] 0.00109569506731
Measured [qlco] 0.00109556299608
Improvement [cnce] 0.00109329348673
Make [ftcn] 0.00108256291217
PREVENT [phsu] 0.00107595126587
Combined [qlco] 0.00107240979556
Metabolic syndrome [dsyn] 0.00105455683388
randomized [resa] 0.00104963293469
practice [menp] 0.00104810256683
Information [idcn] 0.0010462505032
Benefit [qnco] 0.00103744758027
Heart disease [dsyn] 0.00103421912032
symptoms [ftcn] 0.00101834895371
Drug Therapy [topp] 0.00100959908878
Large [qnco] 0.00100234419338
Examined [fndg] 0.000987559320021
Estrogen [horm, phsu, strd] 0.000981570592002
Independent [idcn] 0.000979458628121
Drug [phsu] 0.000967162600424
LTD [ortf] 0.000958627005413
Controlled [ftcn] 0.000951052386899
placebo [topp] 0.000946825209289
Radiation [npop] 0.000943762690092
Often [tmco] 0.000939592191719
ischaemic heart disease [dsyn] 0.000938560978296
Atherosclerosis [dsyn] 0.00093757125581
Sex [orgf] 0.000937371432652
History [ocdi] 0.000936573379056
experience [menp] 0.00093612351523
coronary [bpoc] 0.000927159306682
Conduct [inbe] 0.000924246598985
Score [qnco] 0.00092186206962
Response [orga] 0.000914489320952
Elderly [popg] 0.00091363847469
Benefits [qnco] 0.000907712250022
Medical [ftcn] 0.000907439516895
Acute myocardial infarction [dsyn] 0.000905764076928
Irradiation [npop] 0.00090454519051
Support [medd] 0.000902448883279
Searched [acty] 0.000902268724208
Occurred [acty] 0.000890167580173
search [inpr] 0.000884169732996
Last [qlco] 0.000881734482237
cardiovascular events [fndg] 0.00088117564113
People [popg] 0.000877831535715
Comparison [acty] 0.000876764510326
Aged [orga] 0.000873399021186
Issue [fndg] 0.00086061042664
Mechanisms [ftcn] 0.000857758453302
Adherence [ftcn] 0.000855239469923
Single [popg] 0.00085434049027
GY [geoa] 0.000852465615601
Long [qlco] 0.000852279231572
Characteristics [qlco] 0.000840469180264
Plasma [bdsu] 0.000838389165329
Aspirin [orch, phsu] 0.000835127285541
Risks [qlco] 0.000834699979087
setting [ftcn] 0.000833282345881
weeks [tmco] 0.000830444415011
Known [qlco] 0.000828105024819
Stage [tmco] 0.000827280324213
Evaluation [ftcn] 0.000825112084117
Treatments [topp] 0.000823608505016
Smoking [inbe] 0.000817710068648
Combination [qlco] 0.00081548776479
Future [tmco] 0.000814577852704
Effectiveness [qlco] 0.000813736149476
coronary artery disease [dsyn] 0.000813519539628
Established [qlco] 0.000810291588609
Defined [cnce] 0.000808204373269
lesions [fndg] 0.00080580163552
investigate [ftcn] 0.000804708883201
Limited [ftcn] 0.000801002067313
Physical activity [dora] 0.000800153977967
days [tmco] 0.000798386481338
Hospitalization [hlca] 0.000797135868531
GIVEN [cnce] 0.000796451794715
Likely [qlco] 0.000791559291283
Complex [qlco] 0.000789517920901
Morbidity [qnco] 0.000786590785018
Six [qnco] 0.000786323531312
Report [inpr] 0.000783109680154
Article [inpr] 0.000781223646969
Exercise [dora] 0.000780324483719
Ratio [qnco] 0.000779054017552
vascular [bpoc] 0.000778211585054
Reducing [qlco] 0.000777654562734
Decrease [qlco] 0.000776135459691
strategies [menp] 0.000775342893077
lowering [spco] 0.000770194972049
Needed [qlco] 0.000770105700454
Medications [phsu] 0.000769979187214
Physicians [prog] 0.00076973756192
intervention [hlca] 0.000768635178553
Imaging [diap] 0.000764975975758
Well [qlco] 0.000761842898601
Cost Effectiveness [qnco] 0.000755146417399
Body Mass Index [diap] 0.000753755460599
cardiovascular risk factor [dsyn] 0.000753572156609
Average [qnco] 0.000751011552515
Discharge [bdsu] 0.000750912677081
Decreased [qnco] 0.00074894639261
Agent [chvf] 0.000745664164504
Head [blor] 0.000745578333894
Update [tmco] 0.000743998232044
patient care [hlca] 0.000741172139514
Parameters [fndg] 0.000739743366537
Assessment [hlca] 0.000739480518135
Functional [ftcn] 0.000738347728677
Program [cnce] 0.000738044776953
acute [tmco] 0.000733874810686
Depression [mobd] 0.000733650844366
national [inpr] 0.00073293320698
Confidence Intervals [qnco] 0.000732616072414
findings [ftcn] 0.000729139329058
Breast [bpoc] 0.000719235023427
Obesity [dsyn] 0.000717435700727
radiation therapy [inpr] 0.000712504870592
Relationship [qlco] 0.000704007662369
secondary [neop] 0.000697511568049
Diet [food] 0.000693940776714
Five [qnco] 0.000692070460004
Diseases [dsyn] 0.000691619123644
System [ftcn] 0.000689599373151
Central [spco] 0.000683266336302
Female [fndg] 0.000680487741145
Therapies [topp] 0.000680366106418
Profile [lbpr] 0.000673668920027
Area [geoa] 0.000673210518719
Local [spco] 0.000670892599984
Small [qnco] 0.00066794103382
Ischaemic [ftcn] 0.00066709563921
Prescription [hlca] 0.000666466982811
Increasing [ftcn] 0.000666163056994
Fatal [qlco] 0.000662148342311
Index [inpr] 0.000661055520215
Prostate Cancer [neop] 0.00066104444193
Alone [qnco] 0.000660119672715
free [ftcn] 0.00065502671196
Marker [clna] 0.000654510200474
Comorbidities [idcn] 0.000652453022132
Literature [inpr] 0.000650435840834
Burden [idcn] 0.000650179250522
Chemotherapy [topp] 0.000649181000317
Lipid [lipd] 0.000643668037925
Guide [prog] 0.000642149157142
variables [qlco] 0.000637816987716
Status [qlco] 0.000635057060587
Diabetes Mellitus [dsyn] 0.000635038845073
M NOS [aapp, imft] 0.000633786068064
Take [hlca] 0.00063206264648
Obtained [ftcn] 0.000631053291731
Multiple [qnco] 0.000629869855446
Life Style [socb] 0.000629815343967
???lead [elii, hops] 0.000627378437255
Vascular Malformations [anab] 0.000625803523208
Addition [ftcn] 0.000623851564393
Medication [phsu] 0.000622772628988
Menopause [phsf] 0.000621128319312
With [qlco] 0.000615713581244
Previous [tmco] 0.000615698767457
randomized controlled trials [inpr, resa] 0.000615567979723
Secondary Prevention [topp] 0.000614958757333
function [phsf] 0.00061376534499
Various [irda] 0.00061184347928
statistically significant [qnco] 0.000611086863942
investigated [ftcn] 0.000609694793669
Adult [aggp] 0.000609052741011
Second [qnco] 0.000608853997597
Cardiology [bmod] 0.000607182982214
Clinical Trials [resa] 0.000606289203609
Challenge [clna] 0.000604639906066
Bleeding [patf] 0.000603777822224
Lung Cancer [neop] 0.000603659796391
Part [spco] 0.000603616016398
adverse events [fndg] 0.000602998002299
Duration [tmco] 0.000599470538112
Improving [qlco] 0.000598311105707
APPEAR [qlco] 0.000598213620571
Severe [qlco] 0.000597739060802
Leading [tmco] 0.000597492019741
Proportion [qnco] 0.000595891180754
Dependent [qlco] 0.000594574821419
Values [qlco] 0.000593933133509
Obese [dsyn] 0.000589770104245
Optimal [qlco] 0.00058966298611
Database [inpr] 0.000589029759251
In [qnco] 0.000588600281604
Monitoring [hlca] 0.00058788269704
Affect [menp] 0.000586756171328
Beta-Blockers [phsu] 0.000580853830978
Bias [idcn] 0.000575541971324
Venous Thromboembolism [patf] 0.00057062389778
Decade [qnco] 0.000568816426882
Safety [hcpp] 0.000568051190126
Chronic kidney disease [dsyn] 0.000567427224446
Polypharmacy [fndg] 0.000566998066537
Hospital [hcro, mnob] 0.000566381417602
Died [orgf] 0.000566050330658
size [spco] 0.000565700908086
Acute Coronary Syndrome [dsyn] 0.000565125442164
Late [tmco] 0.000561406364921
Few [qnco] 0.00056140396851
Recommended [idcn] 0.000561021833593
Understanding [menp] 0.000559633682451
lack [qlco] 0.000559163918842
Post [tmco] 0.000555702543725
Symptomatic [ftcn] 0.000552538757687
Dyslipidaemia [dsyn] 0.000551921874747
Provided [acty] 0.00055184571373
Arterial [bpoc] 0.000551790371814
Revealed [qlco] 0.000549906053199
reviewed [inpr] 0.00054583929759
Measures [qnco] 0.000543256952759
Inflammatory [ftcn] 0.000542197871021
Patterns [spco] 0.000541899971825
Length [qnco] 0.000541763678926
Oral [spco] 0.00054107992953
Adults [aggp] 0.000541046313334
Concern [idcn] 0.000539978098114
chronic [tmco] 0.000539303190891
Process [bpoc] 0.000538914141491
Systolic blood pressure [clna] 0.000538601201938
Tool [mnob] 0.000536830899349
Normal [qlco] 0.000536507962514
heart rate [clna] 0.000536416096947
Associations [menp] 0.000535701723075
Administration [ocac] 0.000533940571131
Link [inpr] 0.000533523259541
Test [lbpr] 0.000533521727437
paediatric [bmod] 0.000533343581949
Primary Prevention [topp] 0.000532200624033
Administered [ftcn] 0.000528922074546
hypertensive [fndg] 0.000528465160775
deaths [orgf] 0.000527206022499
prognostic [inpr] 0.000525077776432
Pain [sosy] 0.000524225071486
Primary Care [hlca] 0.00052380211442
strategy [menp] 0.000521521883447
Metabolic [ftcn] 0.000520975335329
criteria [inpr] 0.000520202094169
Low dose [qnco] 0.000516611333675
recommendations [idcn] 0.000516399990401
Recently [tmco] 0.000514856781183
Order [inpr] 0.000514555294025
Action [ftcn] 0.000514418229626
retrospective [resa] 0.000512634985494
Meta-Analysis [inpr] 0.000512214569704
Age-Years [tmco] 0.000511843768079
Center [spco] 0.000511434652584
Flow [npop] 0.000511406543055
Play [dora] 0.000509144295818
matched [resa] 0.00050788132969
Radiotherapy, Intensity-Modulated [topp] 0.000507519949381
left sided [spco] 0.000504729526937
Pulmonary arterial hypertension [dsyn] 0.000503251189367
Ageing [orgf] 0.000502314813445
Questionnaire [inpr] 0.000501373708146
Ethanol [orch] 0.00049716693127
Screening [hlca] 0.000496708208386
prospective [resa] 0.000494340508663
High dose [qnco] 0.000494293435433
Value [qnco] 0.000493969672557
side effects [ftcn] 0.000493360483649
Surgical [hlca] 0.000492922835007
Address [inpr] 0.000492504838375
Contribute [acty] 0.000490622448366
procedures [inpr] 0.000490225194048
Exposure NOS [inpo] 0.000487562611181
Echocardiography [diap] 0.000486387907141
Eight [qnco] 0.000485678619133
Gender [orga] 0.000485504448934
Critical [qlco] 0.000483431764465
Initiation [menp] 0.000482303445459
Structural [spco] 0.000480501020469
Collected [idcn] 0.000479985147585
Renal [bpoc] 0.000477513225865
Select [acty] 0.000476711807485
Pre-operative [tmco] 0.000476620222518
Revascularisation [topp] 0.000473027469791
Alternative [cnce] 0.000471870682998
Required [ftcn] 0.000471748246291
Biological [bmod] 0.000471543856209
Strong [qlco] 0.000470052816481
Consecutive [qlco] 0.000468948527384
American [popg] 0.000468723322743
topic4
P NOS [aapp, imft] 0.0114033144338
treatment [ftcn] 0.00827091099155
Study [mnob] 0.00609888826413
Women [popg] 0.00544591339255
Cardiovascular disease [dsyn] 0.00518117024591
Mortality [qnco] 0.00432526383045
Methods [inpr] 0.00422267312649
CARDIOVASCULAR [bdsy] 0.00408306267297
Trial [resa] 0.00400777150724
Increased [qnco] 0.00396446757634
Age [orga] 0.00377497284665
Conclusions [idcn] 0.00362698582864
Group [idcn] 0.00354367554404
Based [ftcn] 0.00320650764813
Compared [acty] 0.00314377561003
participants [popg] 0.00314098275089
N NOS [aapp, imft] 0.00293844474547
treated [topp] 0.00288118718032
effects [qlco] 0.00272006741155
Men [popg] 0.00264944545051
Hypertension [dsyn] 0.00262757425402
radiotherapy [inpr] 0.00259071155242
Survival [acty] 0.00242006232441
Hazard Ratio [qnco] 0.00240628735921
Stroke [dsyn] 0.00236592840569
included [ftcn] 0.00236074224465
Quality [qlco] 0.00227168393266
months [tmco] 0.0022527452212
Heart [bpoc] 0.00221016411402
Health [idcn] 0.0022068867244
Diabetes [dsyn] 0.00216140982232
therapy [ftcn] 0.00213310663248
Life [idcn] 0.00204868386205
Complications [patf] 0.00200048574539
Performed [ftcn] 0.00195170228405
Management [ocac] 0.00194182311323
IMPACT [gngm] 0.00188778744235
Evaluate [ftcn] 0.00184686880844
Specific [qlco] 0.00182427391721
Cardiac [bpoc] 0.00181018395469
Reported [inpr] 0.00180162418898
Breast Cancer [neop] 0.00178208886572
Suggest [idcn] 0.0017718852319
Efficacy [qlco] 0.00176756222083
Surgery [bmod] 0.00173392715587
Primary [qlco] 0.00168151529083
Objective [inpr] 0.00165188027041
risk factors [qnco] 0.00163182514443
Care [acty] 0.00162327704106
Association [menp] 0.0016136166933
Observed [ftcn] 0.00161196147469
Dose [qnco] 0.00160595631031
effective [qlco] 0.00159772571688
Assessed [acty] 0.00157753681306
Old [tmco] 0.00154259882526
Evaluated [ftcn] 0.00154239030766
Odds Ratio [qnco] 0.0015042508667
Controlled [ftcn] 0.00148914033109
Including [ftcn] 0.00148913202752
Prevention [topp] 0.0014836165972
reduction [npop] 0.00146463471137
Range [qnco] 0.00143073145834
Score [qnco] 0.00142925974845
Induced [ftcn] 0.00142769766086
intervention [hlca] 0.00141959720626
Cases [ftcn] 0.00140409074579
condition [dsyn] 0.00139624764983
High Risk [qlco] 0.00139482573548
Conduct [inbe] 0.00139344196495
Blood Pressure [orgf] 0.00139268829782
Radiation [npop] 0.00136612771902
Levels [qlco] 0.00135491412135
Reduced [qlco] 0.00135186026643
Present [qnco] 0.00135127469818
baseline [bodm] 0.00135069210259
Statins [orch, phsu] 0.00133017063134
Heart failure [dsyn] 0.00130705288872
Identified [qlco] 0.0013052546071
Safety [hcpp] 0.00128031108556
placebo [topp] 0.00127642100827
Therapeutic [topp] 0.00124941521651
People [popg] 0.00122905394817
search [inpr] 0.00122769053674
Statin [orch, phsu] 0.0012263108636
Aspirin [orch, phsu] 0.00121784354702
Sclerotherapy [topp] 0.00121219123348
Authors [prog] 0.00120954020782
cardiovascular events [fndg] 0.00120674222569
Effectiveness [qlco] 0.001202820118
coronary heart disease [dsyn] 0.00119894412104
Prognostic Factor [clna] 0.0011982886622
Subject [grup] 0.00118808057067
Reserve [acty] 0.00118800079967
Current [tmco] 0.00118768869537
Drug [phsu] 0.00118295768223
Available [ftcn] 0.00116533877905
Estrogen [horm, phsu, strd] 0.00116097862098
Improved [qlco] 0.00115850344684
Target [ftcn] 0.0011540300229
Myocardial Infarction [dsyn] 0.00113622574254
Benefit [qnco] 0.00112998148478
Purpose [ftcn] 0.00112714439525
Received [qlco] 0.00112296317767
Large [qnco] 0.00111327363269
Main [qlco] 0.00110423556589
Design [acty] 0.00110048452934
findings [ftcn] 0.00109313977742
Approach [spco] 0.00109225101838
Venous malformation [anab] 0.00108846636615
Metabolic syndrome [dsyn] 0.0010881923125
practice [menp] 0.00107994942771
interventions [hlca] 0.00106964789808
Irradiation [npop] 0.00106946875375
Atrial Fibrillation [patf] 0.00106616485587
postmenopausal [tmco] 0.00106418494767
objectives [inpr] 0.00106276643412
Chronic kidney disease [dsyn] 0.00105538186458
GY [geoa] 0.00104609474338
Decrease [qlco] 0.00104512954583
Guidelines [inpr] 0.00104425798556
Need [qlco] 0.00103926505608
Five [qnco] 0.00103806351005
vascular [bpoc] 0.00103758048216
Drugs [phsu] 0.00103703609401
Confidence Intervals [qnco] 0.00103137193771
Make [ftcn] 0.00102687666329
Following [tmco] 0.00101703597194
Measured [qlco] 0.00101678244297
Published [ocac] 0.00101633530191
Support [medd] 0.0010017725008
Receive [qlco] 0.00100033184587
Several [qnco] 0.000990172014056
symptoms [ftcn] 0.000987711732884
Prostate Cancer [neop] 0.000978618922143
Mechanisms [ftcn] 0.000972719283841
Drug Therapy [topp] 0.000971177366732
Multiple [qnco] 0.000969979968802
days [tmco] 0.00096533635929
Menopause [phsf] 0.000959780110419
setting [ftcn] 0.000959581089625
Addition [ftcn] 0.000959542954407
Comorbidities [idcn] 0.000957102162706
Complex [qlco] 0.000956015255813
Often [tmco] 0.000955720221093
Hormone replacement therapy [topp] 0.000950735483577
Aged [orga] 0.000948850552221
Parameters [fndg] 0.000945647818641
Issue [fndg] 0.000938149913902
Improvement [cnce] 0.000935879532897
Medication [phsu] 0.000935794958263
Atherosclerosis [dsyn] 0.000929042991245
chronic [tmco] 0.000927712763127
Obesity [dsyn] 0.000924227577408
Medical [ftcn] 0.000923864627451
Lipid [lipd] 0.000921381509574
coronary artery disease [dsyn] 0.000913885439847
ischaemic heart disease [dsyn] 0.000912892682342
Increasing [ftcn] 0.00090702737475
Events [evnt] 0.000897007051244
Long [qlco] 0.000889187069483
Combination [qlco] 0.000884201957873
national [inpr] 0.000873847423026
Sex [orgf] 0.000864347153637
Children [aggp] 0.000859440139434
Needed [qlco] 0.000857262671427
Searched [acty] 0.000855815522775
Morbidity [qnco] 0.00085070321701
Diagnosed [fndg] 0.00084820331813
Report [inpr] 0.00083915222307
Independent [idcn] 0.000835150330295
lesions [fndg] 0.000829026886228
Young [tmco] 0.000828493434078
Adjusted [ftcn] 0.000825684210996
Single [popg] 0.000820264987795
Defined [cnce] 0.000819937126274
considered [idcn] 0.000819454831234
Limited [ftcn] 0.00081631012374
History [ocdi] 0.000816277892948
Severe [qlco] 0.000815843676502
Article [inpr] 0.000814496673874
function [phsf] 0.000811872277093
Occurred [acty] 0.000809894912147
Oral [spco] 0.000808677654828
Burden [idcn] 0.000808113564875
Profile [lbpr] 0.000794044161023
Evaluation [ftcn] 0.00079116465568
weeks [tmco] 0.000790923137597
Combined [qlco] 0.000787846574887
Additional [ftcn] 0.000784718277315
Decreased [qnco] 0.000784592264516
experience [menp] 0.000780551796643
Elderly [popg] 0.000780172800962
Diseases [dsyn] 0.000779346353347
cardiovascular risk factor [dsyn] 0.000777831215722
Reducing [qlco] 0.000776254496872
C-reactive protein [aapp, imft] 0.000773081441207
Known [qlco] 0.000770707290532
Likely [qlco] 0.000769512172099
coronary [bpoc] 0.00076751310891
Previous [tmco] 0.000766043873856
Established [qlco] 0.000763403084799
Survivors [podg] 0.000762732065297
Adherence [ftcn] 0.000761902960505
Cost Effectiveness [qnco] 0.000760007795148
Local [spco] 0.000759886398105
Review, Systematic [inpr] 0.000756174924157
Risks [qlco] 0.000755162980509
Estimated [qnco] 0.000753918731047
investigate [ftcn] 0.000753644252805
Index [inpr] 0.000751267997496
Meta-Analysis [inpr] 0.000745726628324
Characteristics [qlco] 0.000738886491525
Imaging [diap] 0.000738502108483
adverse events [fndg] 0.000736631689256
Female [fndg] 0.000736167343844
Central [spco] 0.000735350388216
Future [tmco] 0.000734086569901
Ratio [qnco] 0.000725166890167
Exercise [dora] 0.000722362700615
Appropriate [qlco] 0.000719071099863
Hospital [hcro, mnob] 0.000717811902808
randomized [resa] 0.000717293429319
strategies [menp] 0.000716278097789
Fatal [qlco] 0.000715848013744
Functional [ftcn] 0.000713577074205
Affect [menp] 0.00070976153097
Alone [qnco] 0.000707664582207
Therapies [topp] 0.000701381237896
Physicians [prog] 0.000698930673294
Benefits [qnco] 0.000698428994231
Standard [qlco] 0.000698269660749
Dyslipidaemia [dsyn] 0.000693198323354
PREVENT [phsu] 0.000690753480587
Comparison [acty] 0.000690006652682
Response [orga] 0.000689712911451
Presented [idcn] 0.000688652586881
prognostic [inpr] 0.000687905707815
Update [tmco] 0.000686465744049
Heart disease [dsyn] 0.000684540328009
Database [inpr] 0.000684039185923
Examined [fndg] 0.000680755408546
Marker [clna] 0.000676132018872
Chemotherapy [topp] 0.000675055315689
free [ftcn] 0.000674160518988
Cardiology [bmod] 0.000673816380768
Average [qnco] 0.000669788945684
Relationship [qlco] 0.000668914429723
Address [inpr] 0.000667106645241
Center [spco] 0.000666324788838
M NOS [aapp, imft] 0.000665045760673
Last [qlco] 0.0006627483065
Medications [phsu] 0.000662348560425
Novel [tmco] 0.000661845196549
Body Mass Index [diap] 0.000656792511954
Select [acty] 0.00065417828223
In [qnco] 0.000653903354189
Small [qnco] 0.000652042207174
Vascular Malformations [anab] 0.00064967968267
Take [hlca] 0.000644991252897
Plasma [bdsu] 0.00064410382605
Moderate [qlco] 0.000638857076916
Normal [qlco] 0.000638511300427
reviewed [inpr] 0.000638244666751
Obtained [ftcn] 0.000635742797605
Help [socb] 0.000634950141372
???lead [elii, hops] 0.000634514080256
Assessment [hlca] 0.000632571059273
Well [qlco] 0.000632421954724
APPEAR [qlco] 0.000630172278447
Discharge [bdsu] 0.000630075462803
Recommended [idcn] 0.000629892242737
Understanding [menp] 0.000627638747737
Bleeding [patf] 0.000623332618472
Six [qnco] 0.000622972687736
Few [qnco] 0.00062016374203
Concern [idcn] 0.000619748542713
strategy [menp] 0.000619396046848
Diabetes Mellitus [dsyn] 0.000619197516291
Revealed [qlco] 0.000617818739851
Depression [mobd] 0.000615370592791
Cost [qnco] 0.000611650045183
Secondary Prevention [topp] 0.000607472520195
Stage [tmco] 0.000605697311699
Literature [inpr] 0.000602511163814
Breast [bpoc] 0.000599887548314
Primary Care [hlca] 0.000597950783439
Relevant [qlco] 0.000597924438544
Diet [food] 0.000596185014913
Relative [famg] 0.00059502705522
Agent [chvf] 0.00059118034703
Leading [tmco] 0.00058712716625
Focus [spco] 0.00058574007313
criteria [inpr] 0.000584354566684
Adults [aggp] 0.000580687335087
deaths [orgf] 0.00057690141777
GIVEN [cnce] 0.000575371607914
patient care [hlca] 0.000573537024768
Physical activity [dora] 0.000570332410098
side effects [ftcn] 0.000567605289159
Values [qlco] 0.000567146873439
Prescription [hlca] 0.000566404599259
glycemia [carb] 0.000565605023988
With [qlco] 0.000562117621473
Procedure [diap, topp] 0.000560964362245
Duration [tmco] 0.000560674087032
mmHg [qnco] 0.000560083193382
Neck [blor] 0.000556823405977
Decade [qnco] 0.000556060928935
System [ftcn] 0.000555533590811
Measures [qnco] 0.000553922067694
Systemic [ftcn] 0.000551668771519
Ischaemic [ftcn] 0.000551622092322
techniques [inpr] 0.000551418663092
rats [mamm] 0.000549941186217
Various [irda] 0.000549467663725
secondary [neop] 0.000549259779154
activity [dora] 0.000549021275654
Gender [orga] 0.000539874411843
Interaction [ftcn] 0.000538393065409
Proportion [qnco] 0.000535502172444
prospective [resa] 0.000535378612319
Critical [qlco] 0.000530832190263
LTD [ortf] 0.000530800547754
Of [spco] 0.000530502680127
Administration [ocac] 0.000529937508312
Predicted [idcn] 0.000529134283511
Postoperative [tmco] 0.000529111740206
Inflammatory [ftcn] 0.000528328728421
Primary Prevention [topp] 0.000528097942241
recommendations [idcn] 0.000525969273706
Session [evnt] 0.000524524265921
Regression [patf] 0.000523294316081
Guide [prog] 0.00052272553906
society [orgt] 0.000522101680973
Surgical [hlca] 0.000521840471931
Associations [menp] 0.00052145901629
Myocardial [spco] 0.0005208683938
Second [qnco] 0.000519740521072
Challenge [clna] 0.00051877918969
Information [idcn] 0.000517041400032
heart rate [clna] 0.000514770527547
Venous Thromboembolism [patf] 0.000514337297978
lack [qlco] 0.000508975256606
Revascularisation [topp] 0.000508596313055
Consecutive [qlco] 0.000506652024393
Hospitalization [hlca] 0.000505401523501
Arterial [bpoc] 0.000505263440596
Cholesterol [bacs, strd] 0.000504735799395
acute [tmco] 0.000504508830856
Treatments [topp] 0.000503925337672
paediatric [bmod] 0.000503923225251
Provided [acty] 0.000503315582414
lowering [spco] 0.000502751755571
Acute Coronary Syndrome [dsyn] 0.000502008020883
Comprehensive [qlco] 0.000501296080036
Link [inpr] 0.000500721206912
Androgen Deprivation Therapy [topp] 0.000499941673333
Bias [idcn] 0.000499622976908
Lung Cancer [neop] 0.000498506066584
Congenital heart disease [cgab, dsyn] 0.000496559405174
Required [ftcn] 0.000496217557272
statistically significant [qnco] 0.000494349833319
Polypharmacy [fndg] 0.000492948473273
Post [tmco] 0.0004915531675
Strong [qlco] 0.000490744129052
Collected [idcn] 0.000489350220325
Ageing [orgf] 0.00048870369995
Approaches [spco] 0.000487707125057
Countries [geoa] 0.000487676577953
Represent [acty] 0.000487385210995
majority [socb] 0.000486420202884
Tool [mnob] 0.000486022055467
variables [qlco] 0.000485573252556
American [popg] 0.000485359129216
Acute myocardial infarction [dsyn] 0.000485284817816
Diagnostic [fndg] 0.000484920982618
prescribed [hlca] 0.000484842973335
Pulmonary arterial hypertension [dsyn] 0.000484567843528
Severity [qlco] 0.00048434754791
Antihypertensive [phsu] 0.000481285996703
malformations [ftcn] 0.000478965161888
Onset [qlco] 0.000478500111016
Involving [ftcn] 0.000478243640709
MEDLINE [inpr] 0.000477362641705
Test [lbpr] 0.000477273246972
progression [patf] 0.000476992329296
Head [blor] 0.000476739435883
Action [ftcn] 0.000475897868657
Improving [qlco] 0.000474595090816
Smoking [inbe] 0.000474546338672
Technique [ftcn] 0.000474121438523
Contribute [acty] 0.000473732955571
Flow [npop] 0.000471908028238
Adult [aggp] 0.000471836756243
occurrence [ftcn] 0.000470332553409
retrospective [resa] 0.000470284029508
Area [geoa] 0.000469461965505
Irradiated [ftcn] 0.000468789670898
Cardiovascular Diseases [dsyn] 0.000468786723577
Symptomatic [ftcn] 0.000468575821763
topic5
treatment [ftcn] 0.0107082150175
Study [mnob] 0.00803084961565
P NOS [aapp, imft] 0.00773976157762
Cardiovascular disease [dsyn] 0.00589525528249
Compared [acty] 0.00548443178833
Age [orga] 0.00522104981478
Trial [resa] 0.00460543302263
Methods [inpr] 0.00436195182326
CARDIOVASCULAR [bdsy] 0.0043042326455
Women [popg] 0.00420187656672
Hypertension [dsyn] 0.00387639631882
Increased [qnco] 0.00357076752545
Mortality [qnco] 0.00345741471767
Group [idcn] 0.00319672557174
included [ftcn] 0.00314454288821
treated [topp] 0.00311846122949
participants [popg] 0.00301473752287
Conclusions [idcn] 0.00294003146851
effects [qlco] 0.00288653706194
Based [ftcn] 0.00264757636218
Health [idcn] 0.00258075675123
Cardiac [bpoc] 0.00239190694011
Quality [qlco] 0.00235402631641
Heart failure [dsyn] 0.00228496474414
Survival [acty] 0.00214363466572
Diabetes [dsyn] 0.00211551529015
therapy [ftcn] 0.0020863834296
Odds Ratio [qnco] 0.00208510510593
Association [menp] 0.00205672390832
Stroke [dsyn] 0.00204885880693
Men [popg] 0.00201458380683
radiotherapy [inpr] 0.00198074322601
Breast Cancer [neop] 0.0019697651692
N NOS [aapp, imft] 0.00192024873936
Management [ocac] 0.00189742321958
months [tmco] 0.0018643017459
Observed [ftcn] 0.00185113148182
Specific [qlco] 0.0018113895095
Performed [ftcn] 0.00177826470785
Hazard Ratio [qnco] 0.00177627314248
Including [ftcn] 0.00177618318416
Reduced [qlco] 0.00176926029999
Present [qnco] 0.00175317050845
Assessed [acty] 0.00169673761525
High Risk [qlco] 0.0016947251385
Primary [qlco] 0.00169257881984
Drug [phsu] 0.00165587243161
risk factors [qnco] 0.00165140475367
Complications [patf] 0.00164616623811
intervention [hlca] 0.00161249636207
Need [qlco] 0.00157654748258
Efficacy [qlco] 0.00155224978654
Reported [inpr] 0.0015352766043
Children [aggp] 0.00152197574077
Evaluate [ftcn] 0.00151961685384
effective [qlco] 0.00151626900689
Surgery [bmod] 0.00148738789366
Reserve [acty] 0.00148717092902
Evaluated [ftcn] 0.00146414941221
Suggest [idcn] 0.00142557773324
Heart [bpoc] 0.00142363746874
IMPACT [gngm] 0.00141523363019
Survivors [podg] 0.00140777381751
Levels [qlco] 0.00139859642161
Range [qnco] 0.00138797638282
Venous malformation [anab] 0.00137883333444
Care [acty] 0.00137545504793
People [popg] 0.00136647152513
Myocardial Infarction [dsyn] 0.00136461653702
Statin [orch, phsu] 0.00134671089491
coronary heart disease [dsyn] 0.00134025478597
Therapeutic [topp] 0.00133201217609
cardiovascular events [fndg] 0.00132734087969
Objective [inpr] 0.00131095842305
Parameters [fndg] 0.00128645523388
Prevention [topp] 0.00128136221335
Adjusted [ftcn] 0.00127312553778
Metabolic syndrome [dsyn] 0.00126940424806
Receive [qlco] 0.00124881313668
Dose [qnco] 0.00124779159843
Atrial Fibrillation [patf] 0.00123342222706
Old [tmco] 0.00122255167758
Irradiation [npop] 0.00119746997523
Improvement [cnce] 0.00119240203381
Purpose [ftcn] 0.00118849041164
Atherosclerosis [dsyn] 0.00117850521943
Confidence Intervals [qnco] 0.00117056312028
Main [qlco] 0.00117040212301
findings [ftcn] 0.00116031445245
Limited [ftcn] 0.00115870204179
reduction [npop] 0.00115640545228
Available [ftcn] 0.00115527452223
search [inpr] 0.0011543495742
Induced [ftcn] 0.00115411917394
experience [menp] 0.0011477793607
Controlled [ftcn] 0.00114290533742
Benefit [qnco] 0.00113754987817
Update [tmco] 0.00113571800681
Radiation [npop] 0.00113326941589
Identified [qlco] 0.00112641712691
symptoms [ftcn] 0.00112186938143
Life [idcn] 0.00111589988463
Design [acty] 0.00111510087488
Following [tmco] 0.00111347561801
practice [menp] 0.00110266857835
Current [tmco] 0.00109966280692
Published [ocac] 0.00109763666916
placebo [topp] 0.00108858330091
postmenopausal [tmco] 0.0010862785139
Article [inpr] 0.00108603394372
Drugs [phsu] 0.00108243953906
Target [ftcn] 0.00107290961766
Searched [acty] 0.00105986614731
C-reactive protein [aapp, imft] 0.00105288710488
Additional [ftcn] 0.00104736226187
Sclerotherapy [topp] 0.00104584233068
interventions [hlca] 0.00104250183277
objectives [inpr] 0.00104242580238
Comorbidities [idcn] 0.0010402529336
Score [qnco] 0.00103544178784
ischaemic heart disease [dsyn] 0.00102186466083
Hormone replacement therapy [topp] 0.0010182748911
condition [dsyn] 0.000997985148037
Guidelines [inpr] 0.000997247201613
coronary artery disease [dsyn] 0.000992137133968
Chronic kidney disease [dsyn] 0.000987035165903
Medical [ftcn] 0.000979443287681
Severe [qlco] 0.000976839828343
baseline [bodm] 0.000969977216558
Aspirin [orch, phsu] 0.000964090139408
Blood Pressure [orgf] 0.000961679089029
Safety [hcpp] 0.000958218865697
Combined [qlco] 0.000957489771158
Cases [ftcn] 0.000952592462049
Morbidity [qnco] 0.000950805560237
Five [qnco] 0.000943526097554
Six [qnco] 0.00094174032877
Combination [qlco] 0.000941522963914
GY [geoa] 0.000939760488746
Subject [grup] 0.00093915719388
Heart disease [dsyn] 0.000933759409417
Long [qlco] 0.000925260830617
Previous [tmco] 0.000922723640291
Events [evnt] 0.000918450069093
Body Mass Index [diap] 0.000909748211986
Multiple [qnco] 0.000903866983175
strategies [menp] 0.000899844261722
Mechanisms [ftcn] 0.000898293676866
Estrogen [horm, phsu, strd] 0.000897779658298
Index [inpr] 0.000891771733977
Future [tmco] 0.00088927507655
PREVENT [phsu] 0.000884028749746
Evaluation [ftcn] 0.000883152566493
Approach [spco] 0.000877646827633
chronic [tmco] 0.000875950536319
Functional [ftcn] 0.0008747250731
Statins [orch, phsu] 0.000872635796753
Required [ftcn] 0.000871723913826
Defined [cnce] 0.000871369576635
days [tmco] 0.000867199535992
Information [idcn] 0.000867000434343
lesions [fndg] 0.000858004860162
Relationship [qlco] 0.00085718096012
Often [tmco] 0.000850407062074
Characteristics [qlco] 0.000844564433798
Young [tmco] 0.000843575678022
Complex [qlco] 0.000842985127301
Large [qnco] 0.000840695782744
Prognostic Factor [clna] 0.000837785534729
Lipid [lipd] 0.000836308275566
national [inpr] 0.000836116408725
Benefits [qnco] 0.000834062513101
Ratio [qnco] 0.000832427697766
Treatments [topp] 0.000831000645666
Oral [spco] 0.000829311922712
Average [qnco] 0.000826947117986
investigate [ftcn] 0.000825695228467
Obesity [dsyn] 0.000825386603621
Conduct [inbe] 0.000823338554064
Received [qlco] 0.000822845745787
Small [qnco] 0.000820901260667
Decrease [qlco] 0.000818553785657
vascular [bpoc] 0.000817544813103
Established [qlco] 0.000816461480381
Improved [qlco] 0.000815481340867
History [ocdi] 0.000806483875401
Drug Therapy [topp] 0.000802072788068
Make [ftcn] 0.000800765910129
Estimated [qnco] 0.00079831226967
LTD [ortf] 0.000796836452434
Support [medd] 0.000787572146895
Recommended [idcn] 0.000786262341667
Central [spco] 0.000785986030781
Hospital [hcro, mnob] 0.000785853009694
Assessment [hlca] 0.000785372866555
Status [qlco] 0.000784811091084
acute [tmco] 0.000783583932656
Medication [phsu] 0.000783242161499
System [ftcn] 0.000775931098147
setting [ftcn] 0.000775593026922
Known [qlco] 0.000767910839192
Imaging [diap] 0.000766585458992
Address [inpr] 0.000764908633883
randomized [resa] 0.000764452992845
Occurred [acty] 0.000761189116324
deaths [orgf] 0.00075850602753
Diseases [dsyn] 0.000753857913393
Understanding [menp] 0.000753088258933
Likely [qlco] 0.000753027117671
considered [idcn] 0.000747787117802
Physical activity [dora] 0.000744725953027
Acute Coronary Syndrome [dsyn] 0.000744610016496
Venous Thromboembolism [patf] 0.000742677993824
Needed [qlco] 0.000741841766437
Effectiveness [qlco] 0.000739557492095
Issue [fndg] 0.000738658016381
Alone [qnco] 0.000722589774077
Response [orga] 0.000721162021567
Cost Effectiveness [qnco] 0.00072020041453
Reducing [qlco] 0.000714028672588
Decreased [qnco] 0.000713890824715
Independent [idcn] 0.000705034595104
Take [hlca] 0.000699852189894
Cardiology [bmod] 0.000699662707666
Adherence [ftcn] 0.000699020311346
Acute myocardial infarction [dsyn] 0.000698153174388
Center [spco] 0.000695550875244
Elderly [popg] 0.000693610540418
Authors [prog] 0.000691748836426
Comparison [acty] 0.000690677388853
Appropriate [qlco] 0.000689438003503
APPEAR [qlco] 0.000686149907397
Risks [qlco] 0.000685774525113
Aged [orga] 0.000685573832199
Smoking [inbe] 0.000684148603268
M NOS [aapp, imft] 0.000681846264081
Report [inpr] 0.000680066437616
Single [popg] 0.000678443039178
Select [acty] 0.000678412572005
Addition [ftcn] 0.000668736930267
Medications [phsu] 0.000668055985518
Several [qnco] 0.00066203107711
Duration [tmco] 0.000661757589516
Increasing [ftcn] 0.000657222345189
Ethanol [orch] 0.000655322576236
radiation therapy [inpr] 0.000653931865839
In [qnco] 0.000652415205869
Diagnosed [fndg] 0.000651388251448
mmHg [qnco] 0.00065123272414
Database [inpr] 0.000650898584735
Meta-Analysis [inpr] 0.00065001783745
Female [fndg] 0.000649507410442
Examined [fndg] 0.000647990336832
lowering [spco] 0.000647149048721
Relevant [qlco] 0.00064631414395
Well [qlco] 0.00064630859673
progression [patf] 0.000646295557521
Exercise [dora] 0.000640227522841
Measured [qlco] 0.000635495439894
prognostic [inpr] 0.000634124077648
heart rate [clna] 0.000633420560624
Sex [orgf] 0.00063273815008
Literature [inpr] 0.000631058964135
???lead [elii, hops] 0.000630334703758
Prostate Cancer [neop] 0.000628736058756
Physicians [prog] 0.00062244044099
With [qlco] 0.000619694871241
Marker [clna] 0.000619619447733
Relative [famg] 0.000618042871891
Regression [patf] 0.000616061733259
Moderate [qlco] 0.000614260716937
Last [qlco] 0.000614151652688
Hospitalization [hlca] 0.000614091484333
Menopause [phsf] 0.000613745228859
function [phsf] 0.000612041156141
coronary [bpoc] 0.000606300735178
Focus [spco] 0.000605367900697
Renal dysfunction [fndg] 0.000602407026699
Chemotherapy [topp] 0.000601911764167
Profile [lbpr] 0.000600605826745
Depression [mobd] 0.000599028510184
Adult [aggp] 0.000599006487988
reviewed [inpr] 0.000598295932055
Knowledge [inpr] 0.000597201568843
Therapies [topp] 0.00059473188424
Breast [bpoc] 0.000594727109205
Associations [menp] 0.000592409853128
Eight [qnco] 0.000589213568693
Fatal [qlco] 0.000588664216566
Diabetes Mellitus [dsyn] 0.000588609965637
side effects [ftcn] 0.000586566934266
Gender [orga] 0.000585696728561
Collected [idcn] 0.000582520953184
paediatric [bmod] 0.000581001368295
Represent [acty] 0.000579488648294
adverse events [fndg] 0.000579231630149
Obese [dsyn] 0.000578400261615
GIVEN [cnce] 0.000575884240734
Systemic [ftcn] 0.000572084293151
Cells [cell] 0.000571404775206
Surgical [hlca] 0.000570917230114
High sensitivity [lbpr] 0.000570247781394
cardiovascular risk factor [dsyn] 0.000565965452709
Androgen Deprivation Therapy [topp] 0.000562040596958
Vascular Malformations [anab] 0.000558817658642
Late [tmco] 0.0005585255779
Optimal [qlco] 0.000558509485529
rats [mamm] 0.000557375131329
Adults [aggp] 0.000555479272569
Standard [qlco] 0.000554411126046
mice [mamm] 0.000552424188477
Initial [tmco] 0.000551276174632
patient care [hlca] 0.000545352401212
variables [qlco] 0.00054465706916
Play [dora] 0.000540748527716
Obtained [ftcn] 0.000540475591764
Congenital heart disease [cgab, dsyn] 0.000539711181845
Burden [idcn] 0.000539410153032
Consecutive [qlco] 0.000538248777327
Pulmonary arterial hypertension [dsyn] 0.000538129364943
Primary Care [hlca] 0.000538099398269
Program [cnce] 0.000537778821174
Pain [sosy] 0.000537486186686
Cardiovascular Diseases [dsyn] 0.000536311012824
Stage [tmco] 0.00053587277627
Bleeding [patf] 0.000535639293095
weeks [tmco] 0.000533546655212
prescribed [hlca] 0.000529595778444
recommendations [idcn] 0.000529199451966
investigated [ftcn] 0.000526562593883
free [ftcn] 0.000526347515117
Novel [tmco] 0.000525482483991
Decade [qnco] 0.000525268949008
Life Style [socb] 0.000525153051744
Dyslipidaemia [dsyn] 0.000523873499061
Various [irda] 0.000522893836131
randomized controlled trials [inpr, resa] 0.000522159593177
Selection Criteria [qlco] 0.000518418172337
Plasma [bdsu] 0.000517890908104
Area [geoa] 0.00051411114391
Countries [geoa] 0.000512958037727
Estrogens [horm, phsu, strd] 0.000511412918485
Dialysis [npop] 0.000509244015458
procedures [inpr] 0.000507148814722
Derived [qlco] 0.000504047825677
statistically significant [qnco] 0.000502019183217
Irradiated [ftcn] 0.00050183654338
diabetic [fndg] 0.000501204623966
Local [spco] 0.000500989265734
size [spco] 0.000499219817014
Involving [ftcn] 0.000497783128267
Prescription [hlca] 0.000497714074038
Post [tmco] 0.000497182628907
Cost [qnco] 0.000496684537334
Polypharmacy [fndg] 0.00049600830414
Ischaemic [ftcn] 0.000495932529815
Proportion [qnco] 0.000495657419894
Segment [spco] 0.000494492052469
prescribing [hlca] 0.000493476148858
Glomerular Filtration Rate [diap] 0.000493085775965
Inflammatory [ftcn] 0.000493012896591
Review, Systematic [inpr] 0.000491612610825
Action [ftcn] 0.000491143972462
Ageing [orgf] 0.000490791522642
Diet [food] 0.000489124678124
Part [spco] 0.000488476570912
Low Risk [fndg] 0.000487930517414
Inflammation [patf] 0.000487558831557
Bias [idcn] 0.000486085041155
Arterial [bpoc] 0.000485988788124
Screening [hlca] 0.000485061390476
left sided [spco] 0.000484656267801
Guide [prog] 0.00048367827994
majority [socb] 0.000483136895807
Extracted [topp] 0.000480883924435
Complete [qlco] 0.000480832712399
Recently [tmco] 0.000480816412154
Link [inpr] 0.000480744836843
Direct [qlco] 0.000480208093697
Data Collection [resa] 0.000479440041392
Of [spco] 0.000479264946417
Primary Prevention [topp] 0.000475831018975
Ischaemic stroke [dsyn] 0.00047563612507
Postoperative [tmco] 0.000475454540209
Metabolic [ftcn] 0.000475015690817
Renal [bpoc] 0.00047470910305
methodology [inpr] 0.000474030146019
Discharge [bdsu] 0.000473777248169
Classified [clas] 0.000473508233775
Physical [hlca] 0.000473025676014
Cholesterol [bacs, strd] 0.000472072101845
Clinical Trials [resa] 0.000471771916206
Walking distance [fndg] 0.000471655440027
Test [lbpr] 0.000470158137516
Dependent [qlco] 0.000469086243719
Routine [qlco] 0.000468854994926
Pulmonary Disease, Chronic Obstructive [dsyn] 0.000468609254427
Technique [ftcn] 0.000467201104024
Second [qnco] 0.000465470222641
Approaches [spco] 0.000464861582549
topic6
treatment [ftcn] 0.00894693107078
Study [mnob] 0.00833403243703
P NOS [aapp, imft] 0.00830624244259
Group [idcn] 0.0067477976324
Cardiovascular disease [dsyn] 0.00623094009697
Women [popg] 0.00592348676942
Mortality [qnco] 0.00482173561237
Increased [qnco] 0.00476276071134
Methods [inpr] 0.00470697589098
CARDIOVASCULAR [bdsy] 0.00451994690262
Trial [resa] 0.00445012686235
Age [orga] 0.00417367286683
Conclusions [idcn] 0.00346773549711
participants [popg] 0.00326161450089
Based [ftcn] 0.0032518208375
Compared [acty] 0.00320014405998
included [ftcn] 0.00309454060851
treated [topp] 0.00302291738004
Men [popg] 0.00289564133238
Management [ocac] 0.00288831402462
therapy [ftcn] 0.00287271324512
N NOS [aapp, imft] 0.00269512042669
effects [qlco] 0.00258514916344
radiotherapy [inpr] 0.00244420620632
Diabetes [dsyn] 0.00241362267444
Association [menp] 0.00232653359962
Hypertension [dsyn] 0.00230797443473
Health [idcn] 0.00217454874889
Evaluate [ftcn] 0.00205182738232
months [tmco] 0.00202856806026
Including [ftcn] 0.0019721861043
Suggest [idcn] 0.00196120439478
Reduced [qlco] 0.00196036465496
Cardiac [bpoc] 0.00193279337174
Hazard Ratio [qnco] 0.00193080929036
effective [qlco] 0.00189952712628
Stroke [dsyn] 0.00187216958346
Cases [ftcn] 0.00181270634566
Survival [acty] 0.00180536131748
Statins [orch, phsu] 0.00180218058799
risk factors [qnco] 0.00172348573003
Efficacy [qlco] 0.00165253278758
Breast Cancer [neop] 0.00163494795658
Primary [qlco] 0.00162118675992
coronary heart disease [dsyn] 0.00161764063187
IMPACT [gngm] 0.00161464156833
Life [idcn] 0.00161206984382
Complications [patf] 0.00160860488465
Old [tmco] 0.00159937534118
Heart [bpoc] 0.00158186521375
Present [qnco] 0.00157949475236
High Risk [qlco] 0.00157550769717
Surgery [bmod] 0.00156518019645
Atrial Fibrillation [patf] 0.00155613938225
Observed [ftcn] 0.00153268382848
Myocardial Infarction [dsyn] 0.00152917549054
Quality [qlco] 0.00151244906148
Performed [ftcn] 0.0014996407998
Heart failure [dsyn] 0.00145092857246
reduction [npop] 0.00145028852278
Sclerotherapy [topp] 0.00144185044521
Blood Pressure [orgf] 0.001438021744
Objective [inpr] 0.00142608263252
Adjusted [ftcn] 0.00142325828166
Prevention [topp] 0.00141947211377
Odds Ratio [qnco] 0.00140800420049
Assessed [acty] 0.00139520321477
Controlled [ftcn] 0.0013933811672
Following [tmco] 0.00139274517311
Current [tmco] 0.00138175942143
Range [qnco] 0.0013727790657
Evaluated [ftcn] 0.00137072274185
Need [qlco] 0.00136505080386
Confidence Intervals [qnco] 0.00136080328778
Received [qlco] 0.00133613283769
Published [ocac] 0.00132934813749
Reserve [acty] 0.0013272031821
Venous malformation [anab] 0.00132551025927
Often [tmco] 0.00132065200475
cardiovascular events [fndg] 0.0013119260921
Identified [qlco] 0.00130728238787
Guidelines [inpr] 0.00128651830088
Improvement [cnce] 0.00125890757028
Reported [inpr] 0.0012561772727
Diagnosed [fndg] 0.00125347241012
Safety [hcpp] 0.00123051000204
baseline [bodm] 0.00122399562315
Dose [qnco] 0.00122315236537
setting [ftcn] 0.00121104081935
Authors [prog] 0.00118925810873
Hormone replacement therapy [topp] 0.00118915510621
Radiation [npop] 0.00118582622777
Care [acty] 0.00118476697749
Likely [qlco] 0.00118334908621
GY [geoa] 0.00118175194306
placebo [topp] 0.00115085760338
Measured [qlco] 0.00114993168074
Drug [phsu] 0.00112579529142
Severe [qlco] 0.00112351822299
practice [menp] 0.00111992638054
Available [ftcn] 0.00111746648516
Drugs [phsu] 0.00111588135093
Children [aggp] 0.00111369654806
Improved [qlco] 0.0011100594722
Atherosclerosis [dsyn] 0.00110287133049
Estrogen [horm, phsu, strd] 0.00109422172309
Target [ftcn] 0.00107046606135
Chronic kidney disease [dsyn] 0.00106701311758
coronary artery disease [dsyn] 0.00105840794186
Statin [orch, phsu] 0.00105317605411
objectives [inpr] 0.00103986437941
Long [qlco] 0.00103669159379
Support [medd] 0.0010319052477
Score [qnco] 0.00103183053777
Survivors [podg] 0.00102574537209
Index [inpr] 0.00102336933543
Update [tmco] 0.00102267541993
Body Mass Index [diap] 0.00102251799839
Additional [ftcn] 0.00101892401894
Medical [ftcn] 0.00101604210465
Events [evnt] 0.00101494226802
Independent [idcn] 0.00101441186219
Benefit [qnco] 0.00101438710314
randomized [resa] 0.00100684910974
Increasing [ftcn] 0.00100545491286
condition [dsyn] 0.00100092793298
Design [acty] 0.000994734768558
Purpose [ftcn] 0.000989592565742
Specific [qlco] 0.000980299707642
Induced [ftcn] 0.000978783681742
Irradiation [npop] 0.000974602702427
Mechanisms [ftcn] 0.00097020206468
Evaluation [ftcn] 0.000960614472638
Article [inpr] 0.000959027068109
Young [tmco] 0.000955610738424
Conduct [inbe] 0.000955563589162
Metabolic syndrome [dsyn] 0.000955262023625
Combined [qlco] 0.000949978732534
Limited [ftcn] 0.00094951148212
Medication [phsu] 0.000940284151085
Large [qnco] 0.000937911621154
Several [qnco] 0.000936084456212
mmHg [qnco] 0.000935837217329
C-reactive protein [aapp, imft] 0.00092857745452
Therapeutic [topp] 0.000923313108317
Make [ftcn] 0.000918771065246
People [popg] 0.00091723588405
Imaging [diap] 0.000909745763468
Menopause [phsf] 0.000906261231201
Main [qlco] 0.000897770254084
Levels [qlco] 0.000895604803268
Multiple [qnco] 0.000892397258156
Subject [grup] 0.000888612018052
Combination [qlco] 0.000886919867268
Drug Therapy [topp] 0.000886846333384
ischaemic heart disease [dsyn] 0.000885299742207
Response [orga] 0.000884414336118
Obesity [dsyn] 0.00088426015008
Comorbidities [idcn] 0.000883690075181
Adherence [ftcn] 0.000882437551949
postmenopausal [tmco] 0.000882045450543
intervention [hlca] 0.000880768374123
Treatments [topp] 0.000876084174575
Searched [acty] 0.000870427777848
Decreased [qnco] 0.000867755301866
experience [menp] 0.000865370295967
Select [acty] 0.000861342436448
findings [ftcn] 0.000860790425973
considered [idcn] 0.000859039131079
search [inpr] 0.000857697158876
Single [popg] 0.000856920164593
vascular [bpoc] 0.000856861039803
Therapies [topp] 0.000853496490001
Receive [qlco] 0.000851755250333
Last [qlco] 0.000846726108804
Needed [qlco] 0.000844493095887
Depression [mobd] 0.000831604897373
Small [qnco] 0.000829296466825
Female [fndg] 0.000829202951071
Effectiveness [qlco] 0.000824189763174
Assessment [hlca] 0.000817409465889
Issue [fndg] 0.00081644241213
symptoms [ftcn] 0.000812848352445
Appropriate [qlco] 0.000810476489878
Marker [clna] 0.000801993498959
Information [idcn] 0.000801706828552
Characteristics [qlco] 0.000800251794807
Life Style [socb] 0.000799113258898
Oral [spco] 0.000799092279044
Ratio [qnco] 0.000786917776514
Alone [qnco] 0.000783078959712
Future [tmco] 0.000782587031472
strategies [menp] 0.000781240434767
Acute myocardial infarction [dsyn] 0.000775748356775
Approach [spco] 0.000772890156421
Known [qlco] 0.000771521770914
Plasma [bdsu] 0.000768462165854
Parameters [fndg] 0.000767952222014
Five [qnco] 0.000767424208195
national [inpr] 0.000762226815067
Aged [orga] 0.00076161234813
Diseases [dsyn] 0.000760857239377
Associations [menp] 0.000759001386988
APPEAR [qlco] 0.000755051945345
Defined [cnce] 0.000755016054095
Post [tmco] 0.000753153434058
Smoking [inbe] 0.000751602873719
Morbidity [qnco] 0.000748158600539
lesions [fndg] 0.000742925359035
Well [qlco] 0.000739895843666
side effects [ftcn] 0.000733249896819
chronic [tmco] 0.000733020267104
adverse events [fndg] 0.00072415314377
interventions [hlca] 0.000720586566628
Help [socb] 0.000717733701267
In [qnco] 0.000713136919361
Hospital [hcro, mnob] 0.000707612563743
Guide [prog] 0.000706458938873
History [ocdi] 0.000705281991951
Breast [bpoc] 0.00070393377615
Relative Risk [qnco] 0.00070336074059
function [phsf] 0.000702705499874
Heart disease [dsyn] 0.00070262801718
Proportion [qnco] 0.000701236613617
Estimated [qnco] 0.000698770758228
Relevant [qlco] 0.000696232963109
Meta-Analysis [inpr] 0.000694090610544
Six [qnco] 0.000693685042746
Profile [lbpr] 0.000693049039647
coronary [bpoc] 0.000689750383386
Diabetes Mellitus [dsyn] 0.000681212569514
Ischaemic [ftcn] 0.000679277954217
Occurred [acty] 0.000677141029052
Center [spco] 0.000676693853828
Reducing [qlco] 0.000673794113598
Head [blor] 0.000666543674437
investigate [ftcn] 0.000666503358878
Medications [phsu] 0.000663706770014
Complex [qlco] 0.000662950533109
Cardiology [bmod] 0.000662712249152
Adult [aggp] 0.000662161100267
Previous [tmco] 0.000662046808317
secondary [neop] 0.0006607156519
PREVENT [phsu] 0.000652436970287
Chemotherapy [topp] 0.000647350608492
Congenital heart disease [cgab, dsyn] 0.000647311951367
Relationship [qlco] 0.000645828072899
Standard [qlco] 0.00064394688344
GIVEN [cnce] 0.000642449418235
Examined [fndg] 0.00063621430154
Database [inpr] 0.000634800150346
Obese [dsyn] 0.000634357098103
Vascular Malformations [anab] 0.000634019076751
Prognostic Factor [clna] 0.000633942261034
Elderly [popg] 0.000633883147282
Sex [orgf] 0.000633531581485
investigated [ftcn] 0.000633130858227
System [ftcn] 0.00062836972192
retrospective [resa] 0.000626934294673
Status [qlco] 0.000626759301192
Comparison [acty] 0.000625825072235
Report [inpr] 0.000621516242546
Affect [menp] 0.000620954027862
Correlation [qlco] 0.000619540143893
weeks [tmco] 0.000619184271941
Take [hlca] 0.000617154625231
Cost Effectiveness [qnco] 0.000612698785686
Process [bpoc] 0.000611196823364
Estrogens [horm, phsu, strd] 0.000610624539625
Bleeding [patf] 0.000606414816202
Questionnaire [inpr] 0.000606090189328
Address [inpr] 0.000605575082313
Duration [tmco] 0.000600936938813
Lipid [lipd] 0.000598843595427
prospective [resa] 0.000597998383418
Ageing [orgf] 0.00059665548744
Diet [food] 0.000594701258839
Exercise [dora] 0.000593294561677
Recommended [idcn] 0.000593284754817
recommendations [idcn] 0.000592169847286
Obtained [ftcn] 0.000589872214055
Various [irda] 0.000587016785794
Decade [qnco] 0.0005860253511
Lung Cancer [neop] 0.000585298792481
LTD [ortf] 0.00058422670622
Central [spco] 0.000583312928425
Few [qnco] 0.000582785328876
Of [spco] 0.00058148491735
Established [qlco] 0.000581167983643
free [ftcn] 0.00058111682054
Inflammation [patf] 0.00057845754493
Revealed [qlco] 0.000577430988116
Program [cnce] 0.000575256262825
Burden [idcn] 0.000574289840114
Values [qlco] 0.000573930068051
cardiovascular risk factor [dsyn] 0.000573087091839
randomized controlled trials [inpr, resa] 0.000570184332482
Low Risk [fndg] 0.000569785523456
Test [lbpr] 0.000568345227187
hypertensive [fndg] 0.00056735643864
Late [tmco] 0.000567091268269
Cardiovascular Diseases [dsyn] 0.000565422514232
Presented [idcn] 0.000565042001557
Advance [medd] 0.00056331359974
Glomerular Filtration Rate [diap] 0.000561446312087
strategy [menp] 0.000561038932985
acute [tmco] 0.000557437951812
M NOS [aapp, imft] 0.00055729601559
Functional [ftcn] 0.000555897535901
Understanding [menp] 0.00055542106099
Required [ftcn] 0.00055479258335
Calculated [ftcn] 0.00055387215894
Postoperative [tmco] 0.000553140114761
Physicians [prog] 0.00055152668161
Optimal [qlco] 0.00055054571964
Pulmonary arterial hypertension [dsyn] 0.000550415345862
Fatal [qlco] 0.000550117705279
paediatric [bmod] 0.000549916597751
society [orgt] 0.000548384461498
Countries [geoa] 0.000544569516217
Part [spco] 0.000542724530283
Introduction [hlca] 0.000541250874115
Agent [chvf] 0.000540450981049
Variability [cnce] 0.000538592401414
Currently [tmco] 0.000538073610231
criteria [inpr] 0.000537985021137
Average [qnco] 0.000532129411085
Polypharmacy [fndg] 0.000531840886617
rats [mamm] 0.000531131092472
Prostate Cancer [neop] 0.000530606116097
Pain [sosy] 0.000530416437874
Aspirin [orch, phsu] 0.000530378888648
heart rate [clna] 0.000527497746758
Link [inpr] 0.000527404898942
Surgical [hlca] 0.000527184204822
Initiation [menp] 0.000523530421049
Physical activity [dora] 0.000522637753007
Concern [idcn] 0.00052134572701
Moderate [qlco] 0.000520167771958
Structural [spco] 0.000518277132574
Regression [patf] 0.00051800978449
Hospitalization [hlca] 0.00051777955727
Literature [inpr] 0.000516654518364
Stress [fndg] 0.000514320944166
Bias [idcn] 0.000513218684638
Eight [qnco] 0.000511893537572
Flow [npop] 0.000511033683545
Knowledge [inpr] 0.000510893750127
Tool [mnob] 0.000510147705419
deaths [orgf] 0.000508557820838
Direct [qlco] 0.000508004110174
Magnetic Resonance Imaging [diap] 0.000507461943803
Normal [qlco] 0.000505096049308
Dyslipidaemia [dsyn] 0.000502484638034
Clinical Trials [resa] 0.0005019682345
Damage [inpo] 0.000500662146138
Stage [tmco] 0.000499987382229
Arterial [bpoc] 0.000497152876734
Risks [qlco] 0.000496458999667
Area [geoa] 0.000495244951793
Gender [orga] 0.000494663658928
Adults [aggp] 0.000493335159041
Decrease [qlco] 0.000493290089166
progression [patf] 0.000493080109828
Session [evnt] 0.000492538179696
Died [orgf] 0.000492530153815
Play [dora] 0.000492400235148
Improving [qlco] 0.000492393725008
Androgen Deprivation Therapy [topp] 0.000492119367448
Seven [qnco] 0.000492079875407
Novel [tmco] 0.000491406056086
Interaction [ftcn] 0.00049003877063
Benefits [qnco] 0.000489291562188
???lead [elii, hops] 0.000489041316169
Correlated [qlco] 0.000489034170448
Extracted [topp] 0.00048732245563
Acute Coronary Syndrome [dsyn] 0.000484878317748
Beta-Blockers [phsu] 0.000484861142517
Administration [ocac] 0.000482264321295
radiation therapy [inpr] 0.000480841459031
Derived [qlco] 0.000480837603205
Cost [qnco] 0.000480203372015
Patterns [spco] 0.000477890904744
Secondary Prevention [topp] 0.000475678048932
Psoriasis [dsyn] 0.000475089588834
High dose [qnco] 0.000473531526683
variables [qlco] 0.00047324766504
Human [humn] 0.000471608825203
lowering [spco] 0.000469577290199
Classified [clas] 0.000467990987228
American [popg] 0.000467682748517
Symptomatic [ftcn] 0.000466447162875
Active [ftcn] 0.000464188075944
Reference [idcn] 0.000454978937634
Challenge [clna] 0.000454406837058
Prostate [bpoc] 0.00045416485435
Work [ocac] 0.00045413075654
Data Collection [resa] 0.000453699172439
Relative [famg] 0.00045249857251
Onset [qlco] 0.000451757607728
topic7
treatment [ftcn] 0.00869608967848
P NOS [aapp, imft] 0.00757737521542
Cardiovascular disease [dsyn] 0.00624098731659
Study [mnob] 0.00575331288474
Age [orga] 0.00558604621876
Methods [inpr] 0.00554575623481
Group [idcn] 0.00495084073812
Mortality [qnco] 0.00441358963776
Women [popg] 0.00427814390142
CARDIOVASCULAR [bdsy] 0.00423401763164
Trial [resa] 0.00419537966026
Based [ftcn] 0.00379301009605
Compared [acty] 0.00362855093214
Increased [qnco] 0.00359945362003
Conclusions [idcn] 0.0030786007679
included [ftcn] 0.00300185358794
N NOS [aapp, imft] 0.0028160786626
Hypertension [dsyn] 0.00278580936268
effects [qlco] 0.00278203704206
Diabetes [dsyn] 0.00276327669332
Health [idcn] 0.00257040723944
Survival [acty] 0.00253800569145
treated [topp] 0.00244084912041
participants [popg] 0.00243846083449
Quality [qlco] 0.00221919988381
Association [menp] 0.00217313634024
therapy [ftcn] 0.0021655925623
Hazard Ratio [qnco] 0.00214748690314
risk factors [qnco] 0.00211865325291
radiotherapy [inpr] 0.00210603123992
Men [popg] 0.00207894338011
Management [ocac] 0.00205519104179
Heart failure [dsyn] 0.00200732176298
Suggest [idcn] 0.00199354081952
Efficacy [qlco] 0.00197322721721
Including [ftcn] 0.00196192151231
Cardiac [bpoc] 0.00182553343737
Cases [ftcn] 0.00182329987791
Prevention [topp] 0.00180831289946
months [tmco] 0.0017522043198
Specific [qlco] 0.00174347795999
Stroke [dsyn] 0.00172660633707
Venous malformation [anab] 0.00171995671717
Adjusted [ftcn] 0.00170681776518
Assessed [acty] 0.0016789420614
Myocardial Infarction [dsyn] 0.00167683478075
IMPACT [gngm] 0.00165102936643
Levels [qlco] 0.00163244360844
Performed [ftcn] 0.0016271265321
Heart [bpoc] 0.00162618715676
Statins [orch, phsu] 0.00161105509555
Evaluate [ftcn] 0.00160953853251
Present [qnco] 0.00157169284582
Care [acty] 0.00156390374897
reduction [npop] 0.00154375222884
Benefit [qnco] 0.00153378316904
Complications [patf] 0.00150430020311
baseline [bodm] 0.00148914578157
Primary [qlco] 0.00146551065901
Reduced [qlco] 0.00146387722753
Target [ftcn] 0.00143625406888
Identified [qlco] 0.00143616532188
Range [qnco] 0.00142370397243
Approach [spco] 0.00142262727774
Surgery [bmod] 0.00141253162664
Life [idcn] 0.00140924723806
Reserve [acty] 0.00140900660849
cardiovascular events [fndg] 0.00140323301171
Old [tmco] 0.00140181927164
search [inpr] 0.00139760811897
intervention [hlca] 0.00138722843743
High Risk [qlco] 0.00135451139034
Controlled [ftcn] 0.00133795436517
Objective [inpr] 0.00132942740853
Odds Ratio [qnco] 0.00132777668377
Evaluated [ftcn] 0.00130510893436
Sclerotherapy [topp] 0.0012859091679
Known [qlco] 0.00128033888238
effective [qlco] 0.00127072362421
Blood Pressure [orgf] 0.00126832173592
Current [tmco] 0.00126283990152
Purpose [ftcn] 0.00125955629937
Dose [qnco] 0.0012447421032
Subject [grup] 0.0012370036708
Authors [prog] 0.001235106695
ischaemic heart disease [dsyn] 0.00123234247548
Observed [ftcn] 0.00122706368
People [popg] 0.00122440968291
Guidelines [inpr] 0.00121911713451
Children [aggp] 0.00121414469774
Published [ocac] 0.00120699349296
Effectiveness [qlco] 0.00120247415848
Drug [phsu] 0.00119739817075
placebo [topp] 0.00118791189664
Atrial Fibrillation [patf] 0.00118171038186
Irradiation [npop] 0.00117503416809
Support [medd] 0.00117412538266
Main [qlco] 0.00116921123861
Needed [qlco] 0.0011648650306
Score [qnco] 0.00115159837348
Last [qlco] 0.00114430094616
Update [tmco] 0.00114087132901
History [ocdi] 0.00113186921789
Available [ftcn] 0.00113130424064
lesions [fndg] 0.00112961924413
Design [acty] 0.00112217988576
Received [qlco] 0.00111144135128
interventions [hlca] 0.00111136138566
Improvement [cnce] 0.00110746485262
Limited [ftcn] 0.00110515402967
vascular [bpoc] 0.00109770017696
coronary artery disease [dsyn] 0.00109325398786
Improved [qlco] 0.00109300195113
Medications [phsu] 0.0010862862742
condition [dsyn] 0.00108153265411
coronary heart disease [dsyn] 0.001079550874
Survivors [podg] 0.00107741043164
Events [evnt] 0.00107096464486
Measured [qlco] 0.00107041342367
PREVENT [phsu] 0.00106559513735
Complex [qlco] 0.00106555832634
Breast Cancer [neop] 0.0010639367007
Induced [ftcn] 0.00105694410553
Hormone replacement therapy [topp] 0.00105658614621
Single [popg] 0.00105227221236
Radiation [npop] 0.00103859957805
Prognostic Factor [clna] 0.00102993864455
Receive [qlco] 0.00102521464249
Statin [orch, phsu] 0.00102260112874
Therapeutic [topp] 0.00102244475529
Severe [qlco] 0.00101323239736
Reported [inpr] 0.00101152454804
Drugs [phsu] 0.00100345761665
Well [qlco] 0.00100205327712
Atherosclerosis [dsyn] 0.00100166307965
Drug Therapy [topp] 0.00100034161227
Independent [idcn] 0.000997799774837
Acute myocardial infarction [dsyn] 0.000989542730448
strategies [menp] 0.000965405449952
Safety [hcpp] 0.000962337793949
Confidence Intervals [qnco] 0.000959162733015
Aged [orga] 0.000958493352348
Following [tmco] 0.000957309023787
Vascular Malformations [anab] 0.000951782995227
Future [tmco] 0.000951113863835
Estimated [qnco] 0.000948733132841
Diagnosed [fndg] 0.000948468845853
practice [menp] 0.000941849725485
Parameters [fndg] 0.000939433478085
Evaluation [ftcn] 0.000935475710527
Burden [idcn] 0.000926739745124
Several [qnco] 0.000919661204712
national [inpr] 0.000917479750865
postmenopausal [tmco] 0.000917079476104
Young [tmco] 0.000916248496278
Ratio [qnco] 0.000911903554214
Morbidity [qnco] 0.000910176067234
days [tmco] 0.000908885271291
Additional [ftcn] 0.000901867395245
Large [qnco] 0.000900698119716
Center [spco] 0.00090069698395
Benefits [qnco] 0.000898716754283
Often [tmco] 0.000896406701773
Assessment [hlca] 0.000890584068953
findings [ftcn] 0.000887713653839
Issue [fndg] 0.00088625608778
randomized [resa] 0.000877552128958
C-reactive protein [aapp, imft] 0.000876202926903
Chronic kidney disease [dsyn] 0.000874238440102
setting [ftcn] 0.000865688545783
Decreased [qnco] 0.00086173503515
symptoms [ftcn] 0.000860964990041
cardiovascular risk factor [dsyn] 0.000854077557911
Combination [qlco] 0.000853558121645
Adherence [ftcn] 0.000843561837545
Information [idcn] 0.000841677605011
Conduct [inbe] 0.000841212056857
Comparison [acty] 0.000831717685847
Metabolic syndrome [dsyn] 0.000829961171925
Report [inpr] 0.000825395900553
Elderly [popg] 0.00082477793676
Make [ftcn] 0.000820361316862
Exercise [dora] 0.000817455641643
Medical [ftcn] 0.000808088395357
Functional [ftcn] 0.000799454806918
Multiple [qnco] 0.000799425136808
LTD [ortf] 0.000798913918112
Long [qlco] 0.000797637121368
Imaging [diap] 0.000792456251695
Female [fndg] 0.000792144397247
GY [geoa] 0.000788479121123
Appropriate [qlco] 0.000785169414903
Cardiology [bmod] 0.000781718197786
Literature [inpr] 0.00077777392894
chronic [tmco] 0.000774989477614
Take [hlca] 0.00076601249206
Medication [phsu] 0.000765032371483
Help [socb] 0.00076154631567
Decrease [qlco] 0.000761265359988
Article [inpr] 0.000757935822875
Meta-Analysis [inpr] 0.000755944738174
Characteristics [qlco] 0.000753634613409
experience [menp] 0.000752966585719
Obesity [dsyn] 0.000750081721096
System [ftcn] 0.000747439462648
considered [idcn] 0.000745849906993
Menopause [phsf] 0.000744183853908
Six [qnco] 0.000738404986406
Mechanisms [ftcn] 0.000737950817308
Comorbidities [idcn] 0.00073758881382
acute [tmco] 0.000737184433821
Cardiovascular Diseases [dsyn] 0.000734429828588
mmHg [qnco] 0.000734209199594
Examined [fndg] 0.000733206586938
Combined [qlco] 0.00073232338666
Alone [qnco] 0.000726942980239
Diseases [dsyn] 0.000722112062981
Need [qlco] 0.000715176873738
In [qnco] 0.000714292521695
Marker [clna] 0.000714082780659
Treatments [topp] 0.00070956201133
Damage [inpo] 0.000707521807734
recommendations [idcn] 0.000707414183263
Proportion [qnco] 0.000706658636498
Aspirin [orch, phsu] 0.000705085739414
Prostate Cancer [neop] 0.000704256368286
APPEAR [qlco] 0.000704153417137
Body Mass Index [diap] 0.00070379047199
Select [acty] 0.000699299601502
Heart disease [dsyn] 0.000698914831521
coronary [bpoc] 0.000694799241878
Index [inpr] 0.000690553628681
Small [qnco] 0.000688553700766
Guide [prog] 0.000688266490491
Estrogen [horm, phsu, strd] 0.000686923188854
Standard [qlco] 0.00068375967129
Relationship [qlco] 0.000680782995785
Recommended [idcn] 0.00067668823172
Searched [acty] 0.000676075451475
Likely [qlco] 0.000670170735869
objectives [inpr] 0.000669289306328
Acute Coronary Syndrome [dsyn] 0.000667401450529
Optimal [qlco] 0.000663032261087
Increasing [ftcn] 0.000661987585181
investigate [ftcn] 0.000660522550067
Obtained [ftcn] 0.000658262956039
GIVEN [cnce] 0.00065434580628
Collected [idcn] 0.000651437169965
Response [orga] 0.000650178312878
Oral [spco] 0.000648620812914
Bleeding [patf] 0.000647243105978
Diet [food] 0.000645943066399
function [phsf] 0.000645227789687
M NOS [aapp, imft] 0.000643845047108
Average [qnco] 0.000643422800822
Cost Effectiveness [qnco] 0.000642311725114
Addition [ftcn] 0.000642093609873
Plasma [bdsu] 0.000640910615478
Risks [qlco] 0.000640668535768
Lipid [lipd] 0.000640434483965
Discharge [bdsu] 0.000639326881414
rats [mamm] 0.000635533462504
Previous [tmco] 0.000635410011897
Chemotherapy [topp] 0.000635044561714
Adults [aggp] 0.000631394455135
Novel [tmco] 0.000631256360523
Values [qlco] 0.000630461925622
Diagnostic [fndg] 0.000625806822927
Life Style [socb] 0.000625234138513
hypertensive [fndg] 0.000624370688512
Few [qnco] 0.000617885197187
Improving [qlco] 0.000617000988178
Administration [ocac] 0.000615749597792
Head [blor] 0.000615373553374
Represent [acty] 0.000611463892474
criteria [inpr] 0.000609988412926
patient care [hlca] 0.000608530092755
Agent [chvf] 0.000606619457176
Profile [lbpr] 0.000605248382221
Review, Systematic [inpr] 0.000604441516254
secondary [neop] 0.000603436368747
Fatal [qlco] 0.000601929122713
heart rate [clna] 0.000599325561279
society [orgt] 0.000598748742474
Secondary Prevention [topp] 0.000592464429724
Postoperative [tmco] 0.000588797433982
Defined [cnce] 0.000588228983525
Countries [geoa] 0.000584660797355
Adult [aggp] 0.000584561520412
Therapies [topp] 0.000582999954302
Part [spco] 0.00058292921178
weeks [tmco] 0.000578867881598
Inflammation [patf] 0.000576897083462
Recently [tmco] 0.000576763776111
prospective [resa] 0.000576479069096
Local [spco] 0.000574392552723
American [popg] 0.000574379777715
adverse events [fndg] 0.000574299087125
Program [cnce] 0.000572554386801
Late [tmco] 0.000570434142417
procedures [inpr] 0.000569984528418
investigated [ftcn] 0.000569599544078
Hospitalization [hlca] 0.000568712067842
Reducing [qlco] 0.000561717336122
Focus [spco] 0.0005600438868
Moderate [qlco] 0.000558218792636
Stage [tmco] 0.000558044654133
Severity [qlco] 0.000556238342015
Central [spco] 0.000554192344451
Duration [tmco] 0.000552847472754
Alternative [cnce] 0.00055210222184
Process [bpoc] 0.000550818396665
variables [qlco] 0.000549198849683
Presented [idcn] 0.000547347160938
Users [humn] 0.000546439726796
Survey [inpr] 0.000546393395444
Currently [tmco] 0.000544151049942
Smoking [inbe] 0.000542843750624
Affect [menp] 0.00054142878404
Diabetes Mellitus [dsyn] 0.000538685151505
Cost [qnco] 0.000536732151322
Pain [sosy] 0.000535956552674
Address [inpr] 0.000535342748459
Low Risk [fndg] 0.000535166841207
statistically significant [qnco] 0.000534906388958
Clinical Trials [resa] 0.000534683432824
Venous Thromboembolism [patf] 0.000534638998772
Sex [orgf] 0.000531732963002
Regression [patf] 0.000530549198582
reviewed [inpr] 0.00052952049394
Post [tmco] 0.000528413717897
???lead [elii, hops] 0.000525510683484
strategy [menp] 0.000524336394732
Androgen Deprivation Therapy [topp] 0.000521778564019
Relevant [qlco] 0.000521390166055
Derived [qlco] 0.000520112843024
Flow [npop] 0.000519644942613
Tool [mnob] 0.00051813319339
Indicated [fndg] 0.000517297768594
free [ftcn] 0.000517233563711
Five [qnco] 0.000513639299114
Gender [orga] 0.000513009991134
randomized controlled trials [inpr, resa] 0.000512684418647
Ageing [orgf] 0.000512539010246
Congenital heart disease [cgab, dsyn] 0.000511803673281
Died [orgf] 0.000511741907128
prognostic [inpr] 0.000511654233192
Extracted [topp] 0.000509650671533
Active [ftcn] 0.000509318303123
Paper [mnob] 0.000508797424728
Polypharmacy [fndg] 0.000506808263519
Decade [qnco] 0.000505855173109
With [qlco] 0.000505593327061
European [popg] 0.000504361196602
Monitoring [hlca] 0.000502409836392
Physical activity [dora] 0.000500878871579
Inflammatory [ftcn] 0.000499947905478
Bias [idcn] 0.000499689744733
Knowledge [inpr] 0.000498724444421
Test [lbpr] 0.000497997883892
deaths [orgf] 0.000496672438015
Breast [bpoc] 0.00049501746282
Of [spco] 0.000493212221338
Required [ftcn] 0.000492953513547
Link [inpr] 0.00049293613106
Value [qnco] 0.000492710582306
Hospital [hcro, mnob] 0.000492644708405
lack [qlco] 0.000491823940479
Initial [tmco] 0.000489934256203
Revealed [qlco] 0.000489202071809
size [spco] 0.000488368842727
End [spco] 0.000484982199729
Infants [aggp] 0.000483582962678
Ischaemic stroke [dsyn] 0.000483440122093
Familial hypercholesterolaemia [dsyn] 0.000482865948293
majority [socb] 0.000482263006207
Consecutive [qlco] 0.000481232025621
Symptomatic [ftcn] 0.000480326938056
Status [qlco] 0.000480214582047
occurrence [ftcn] 0.000479228235479
Measures [qnco] 0.000478920532213
side effects [ftcn] 0.000478173370704
methodology [inpr] 0.000475092492763
Associations [menp] 0.000474867031928
Relative [famg] 0.000473639318257
Beta [plnt] 0.000473501137904
retrospective [resa] 0.000472804780165
Understanding [menp] 0.00047105692455
Ethanol [orch] 0.00047047037145
Area [geoa] 0.000469485290857
Contrast [qlco] 0.000468700497011
Occurred [acty] 0.000468195824507
Data Collection [resa] 0.000467850875737
Structural [spco] 0.000467253907545
Physicians [prog] 0.000467246872709
paediatric [bmod] 0.000467063786216
Direct [qlco] 0.000465819830814
Applied [hlca] 0.000464288185124
Metabolic [ftcn] 0.000463908639265
mice [mamm] 0.00046336135138
topic8
treatment [ftcn] 0.00904521498537
P NOS [aapp, imft] 0.00790127145591
Study [mnob] 0.00666502890303
Women [popg] 0.00597844419116
Cardiovascular disease [dsyn] 0.00581897244104
Group [idcn] 0.00530074316156
Methods [inpr] 0.00500441588722
Compared [acty] 0.00468289853538
Mortality [qnco] 0.00466599012411
Based [ftcn] 0.00360002799295
CARDIOVASCULAR [bdsy] 0.00356554673612
Age [orga] 0.00347737157773
Hypertension [dsyn] 0.00326046415103
Trial [resa] 0.00316851009006
effects [qlco] 0.00314237639872
Increased [qnco] 0.00293975067077
Survival [acty] 0.00285588722406
Conclusions [idcn] 0.00269509346935
N NOS [aapp, imft] 0.002692941141
treated [topp] 0.0024790401687
Diabetes [dsyn] 0.00245559237902
Health [idcn] 0.00238353852424
included [ftcn] 0.0023827229484
participants [popg] 0.00236377671843
Management [ocac] 0.00234295588791
Surgery [bmod] 0.00232867576648
radiotherapy [inpr] 0.00229196038315
Care [acty] 0.00208406166945
Stroke [dsyn] 0.0020148966524
Efficacy [qlco] 0.0019964789551
Evaluate [ftcn] 0.00191990155628
Including [ftcn] 0.00187999491289
Present [qnco] 0.00186076098173
therapy [ftcn] 0.00182374052015
Cardiac [bpoc] 0.00182005009524
Breast Cancer [neop] 0.00179786180039
Dose [qnco] 0.00178891751406
effective [qlco] 0.00172205599263
Association [menp] 0.00170965154642
Statins [orch, phsu] 0.00169593190702
Quality [qlco] 0.00168184070592
Performed [ftcn] 0.00167523837558
Levels [qlco] 0.00166822709468
Available [ftcn] 0.00164171557323
Myocardial Infarction [dsyn] 0.00161710646784
Published [ocac] 0.00161112634089
Odds Ratio [qnco] 0.00160988406202
Suggest [idcn] 0.00160980784121
Observed [ftcn] 0.00160124272569
Heart [bpoc] 0.00159741232761
Reported [inpr] 0.0015732543291
Venous malformation [anab] 0.00156722527753
IMPACT [gngm] 0.00154548601124
coronary heart disease [dsyn] 0.00154425329464
Hazard Ratio [qnco] 0.00153285839559
Complications [patf] 0.00151066908857
Sclerotherapy [topp] 0.0015048483023
risk factors [qnco] 0.00149788346964
baseline [bodm] 0.00148012368217
Heart failure [dsyn] 0.00147484641208
Assessed [acty] 0.00144831695646
PREVENT [phsu] 0.00144609971753
Reserve [acty] 0.00144461976702
Primary [qlco] 0.00143588949016
Cases [ftcn] 0.00142498931912
months [tmco] 0.00142496291381
Old [tmco] 0.00142374174722
reduction [npop] 0.00140957076935
coronary artery disease [dsyn] 0.00139890872791
Evaluated [ftcn] 0.00139616974516
High Risk [qlco] 0.00139614781727
Receive [qlco] 0.001391508499
placebo [topp] 0.00137275300203
Need [qlco] 0.00136665424287
Identified [qlco] 0.00136291511263
intervention [hlca] 0.00133658033655
People [popg] 0.00131790879286
Reduced [qlco] 0.00129881350401
Appropriate [qlco] 0.00129237147634
condition [dsyn] 0.00129013902695
Comorbidities [idcn] 0.00127780681626
Current [tmco] 0.00126980644798
Blood Pressure [orgf] 0.00125569195383
Objective [inpr] 0.00125472385386
Specific [qlco] 0.00125273025626
Men [popg] 0.00123813414482
Induced [ftcn] 0.00122384351822
Children [aggp] 0.00121483591709
Prevention [topp] 0.0011993268361
Effectiveness [qlco] 0.0011899861787
Adjusted [ftcn] 0.00118557094927
Benefit [qnco] 0.00118379231448
Drug [phsu] 0.00116793245133
Therapeutic [topp] 0.00116655283066
Authors [prog] 0.00115945505809
cardiovascular events [fndg] 0.00115928926389
Safety [hcpp] 0.0011370447224
Irradiation [npop] 0.00112562134296
Radiation [npop] 0.00112337302643
Life [idcn] 0.00111804172124
Target [ftcn] 0.00111463354736
Score [qnco] 0.00111342904054
Purpose [ftcn] 0.00111247565586
objectives [inpr] 0.00110393450778
Controlled [ftcn] 0.00109211438089
GY [geoa] 0.00108999981311
Atrial Fibrillation [patf] 0.00108953945595
Metabolic syndrome [dsyn] 0.00108208374588
findings [ftcn] 0.00108092735417
Main [qlco] 0.00108034010073
Morbidity [qnco] 0.00107326520764
experience [menp] 0.0010695263252
Estrogen [horm, phsu, strd] 0.00106451349897
Limited [ftcn] 0.00106196272754
C-reactive protein [aapp, imft] 0.0010574069142
search [inpr] 0.00103744697708
Severe [qlco] 0.00103353582538
practice [menp] 0.00103300500701
randomized [resa] 0.00102123234799
Prognostic Factor [clna] 0.00101418828067
Received [qlco] 0.00101321521136
Index [inpr] 0.00101114007769
Subject [grup] 0.00100879207301
Medication [phsu] 0.00100084824415
Several [qnco] 0.000999330761643
Large [qnco] 0.000994370537027
Adherence [ftcn] 0.000984688418292
Often [tmco] 0.000984205521507
Approach [spco] 0.000981818779712
Drug Therapy [topp] 0.00098087565523
Guidelines [inpr] 0.000979100475953
Estimated [qnco] 0.000965761928721
Mechanisms [ftcn] 0.000952451044878
Needed [qlco] 0.000950794547289
Aspirin [orch, phsu] 0.000949756215174
Update [tmco] 0.000948823942325
Independent [idcn] 0.000948327437424
interventions [hlca] 0.000943627208263
Events [evnt] 0.000938676242936
Recommended [idcn] 0.000938500661695
Evaluation [ftcn] 0.00093839880918
Medications [phsu] 0.000937101262635
Design [acty] 0.000931857897115
Survivors [podg] 0.000929280974097
Known [qlco] 0.000925871185522
Increasing [ftcn] 0.00091929022284
Drugs [phsu] 0.000918914333483
Conduct [inbe] 0.000914905199585
Aged [orga] 0.00091426529797
postmenopausal [tmco] 0.000911825092134
Article [inpr] 0.00091131317198
Ratio [qnco] 0.000910453078254
Elderly [popg] 0.000905483330807
Select [acty] 0.00090030108986
considered [idcn] 0.000899265176577
Well [qlco] 0.000892308670283
investigated [ftcn] 0.000891829000174
national [inpr] 0.000879049655513
Searched [acty] 0.000874471234959
History [ocdi] 0.000871808326684
Diagnosed [fndg] 0.000870542449428
Combined [qlco] 0.000867862273107
Improved [qlco] 0.00086679137388
Defined [cnce] 0.000866067340168
vascular [bpoc] 0.000865972240628
Future [tmco] 0.000864916617198
Hormone replacement therapy [topp] 0.000864798358902
Statin [orch, phsu] 0.000863156988821
Range [qnco] 0.00086175093411
Support [medd] 0.000857241452159
Body Mass Index [diap] 0.000855493932304
Issue [fndg] 0.000854731178215
Atherosclerosis [dsyn] 0.000851960631486
coronary [bpoc] 0.000848770794721
Information [idcn] 0.000843007270211
Cost Effectiveness [qnco] 0.000842650543497
Make [ftcn] 0.000840579417122
Likely [qlco] 0.000835823887316
Improvement [cnce] 0.000835079415389
chronic [tmco] 0.00083355184153
Acute myocardial infarction [dsyn] 0.000832851729987
Alone [qnco] 0.000830145135504
Five [qnco] 0.000825915293652
Acute Coronary Syndrome [dsyn] 0.000820665108204
Examined [fndg] 0.000815856900149
Decreased [qnco] 0.000811500641295
setting [ftcn] 0.000809542230524
Following [tmco] 0.000806978795834
Characteristics [qlco] 0.000804265308579
Decrease [qlco] 0.00080325489515
Average [qnco] 0.00079532797631
strategies [menp] 0.0007942538088
days [tmco] 0.000788984902616
Chronic kidney disease [dsyn] 0.000787447538691
Combination [qlco] 0.000783649003852
Sex [orgf] 0.000783164747814
symptoms [ftcn] 0.000778720429208
Life Style [socb] 0.000777525660228
Last [qlco] 0.00077493794942
Local [spco] 0.000774708817389
free [ftcn] 0.000774250741962
Imaging [diap] 0.000771209442669
Additional [ftcn] 0.000770715930588
Reducing [qlco] 0.000769990230716
Long [qlco] 0.000766583530657
Head [blor] 0.000766171282567
Six [qnco] 0.000765295078954
Meta-Analysis [inpr] 0.000762512982453
Regression [patf] 0.000762018668267
Chemotherapy [topp] 0.000760857317749
Established [qlco] 0.000760657956559
Required [ftcn] 0.000760629090797
Heart disease [dsyn] 0.000758607759531
Comparison [acty] 0.000754539567216
GIVEN [cnce] 0.000753901307225
Obesity [dsyn] 0.000749425246083
Novel [tmco] 0.000746809507449
Complex [qlco] 0.000745841046299
Multiple [qnco] 0.000741383145744
lesions [fndg] 0.000740394213819
Medical [ftcn] 0.000737232967601
Assessment [hlca] 0.000735888997333
Response [orga] 0.000732533687811
acute [tmco] 0.000729913963047
In [qnco] 0.00072977744706
patient care [hlca] 0.000729421001184
Agent [chvf] 0.000717183779713
Young [tmco] 0.000713595964473
prognostic [inpr] 0.000712887974064
ischaemic heart disease [dsyn] 0.000708206460401
Improving [qlco] 0.000705336814667
Profile [lbpr] 0.000704289655968
Previous [tmco] 0.000703976933063
Cardiovascular Diseases [dsyn] 0.000700996926891
Functional [ftcn] 0.000700768789526
Oral [spco] 0.000698698874708
Parameters [fndg] 0.00069646076091
Burden [idcn] 0.000695165838192
Percutaneous [spco] 0.000692119426747
Lipid [lipd] 0.000692061815924
Hospitalization [hlca] 0.000691876093185
Single [popg] 0.00069157095281
Vascular Malformations [anab] 0.000691282541288
Relationship [qlco] 0.000689296150232
criteria [inpr] 0.000687810693918
Female [fndg] 0.000684862556368
Leading [tmco] 0.000684568925126
Concern [idcn] 0.000684057793044
society [orgt] 0.000675777344364
function [phsf] 0.000674877739417
Treatments [topp] 0.000671689170233
Proportion [qnco] 0.000671443085163
Postoperative [tmco] 0.000670171206549
Myocardial [spco] 0.000667856909764
Report [inpr] 0.000667602072319
mmHg [qnco] 0.000664769242793
Breast [bpoc] 0.000664522645589
secondary [neop] 0.000664068066897
Diseases [dsyn] 0.000659607918433
System [ftcn] 0.000657758686148
Measured [qlco] 0.000656179774836
lowering [spco] 0.000655029854272
Congenital heart disease [cgab, dsyn] 0.000652590696572
Benefits [qnco] 0.000651524876622
Review, Systematic [inpr] 0.0006480208294
Primary Care [hlca] 0.000646425821096
Confidence Intervals [qnco] 0.000645303582297
Menopause [phsf] 0.000644864077403
Adult [aggp] 0.000643100016977
LTD [ortf] 0.000642873682346
APPEAR [qlco] 0.000638156141241
Hospital [hcro, mnob] 0.000637332565711
procedures [inpr] 0.000634141224121
Marker [clna] 0.000633820329482
M NOS [aapp, imft] 0.000632666044124
Bleeding [patf] 0.000632060005931
Various [irda] 0.000629940573918
weeks [tmco] 0.000627511652086
Ethanol [orch] 0.000626385875881
size [spco] 0.000621451052223
Obtained [ftcn] 0.000618654013367
cardiovascular risk factor [dsyn] 0.000616486769045
Diagnostic [fndg] 0.000614909266107
Flow [npop] 0.000612528900537
Damage [inpo] 0.000610551389888
Represent [acty] 0.000608811893203
paediatric [bmod] 0.000607004876465
Cardiology [bmod] 0.00060676944525
Literature [inpr] 0.000605662559362
Tool [mnob] 0.000603949484356
Physical activity [dora] 0.000602292117053
reviewed [inpr] 0.000600036192136
Program [cnce] 0.000599473761772
Adults [aggp] 0.000596794072252
recommendations [idcn] 0.000591958400356
Occurred [acty] 0.000589206249105
Stage [tmco] 0.00058865090031
Part [spco] 0.000587295596392
Database [inpr] 0.000584031654858
Central [spco] 0.000584026080684
Focus [spco] 0.00058300078315
Systemic [ftcn] 0.000581940618045
Multi [qnco] 0.000579997190372
Associations [menp] 0.000578856876549
Risks [qlco] 0.000578132939886
adverse events [fndg] 0.000575492260438
Renal [bpoc] 0.000574729749146
Diet [food] 0.000573814904289
heart rate [clna] 0.000570531347353
Ischaemic [ftcn] 0.000570486031594
Prescription [hlca] 0.000569665364473
Polypharmacy [fndg] 0.000566134348691
Contribute [acty] 0.000564983540735
Length [qnco] 0.00056436927194
strategy [menp] 0.000563498308594
Prostate Cancer [neop] 0.000562768063782
Indicated [fndg] 0.000560778405127
Lung Cancer [neop] 0.000560636721197
Pain [sosy] 0.000559890276184
Venous Thromboembolism [patf] 0.000557467815686
Duration [tmco] 0.000554719068759
Diabetes Mellitus [dsyn] 0.000554063823353
Addition [ftcn] 0.000553327265838
Moderate [qlco] 0.00055241320998
Measures [qnco] 0.000551353058539
Alternative [cnce] 0.000551131205756
Value [qnco] 0.000550996322523
investigate [ftcn] 0.000548374898091
American [popg] 0.000547712052886
Take [hlca] 0.000545744022598
Arterial [bpoc] 0.000545213915026
Therapies [topp] 0.000545120959709
Post [tmco] 0.000543284032373
Center [spco] 0.000543044313192
Pre-operative [tmco] 0.00053803926575
Consecutive [qlco] 0.000536303701476
Late [tmco] 0.000534689902645
Dyslipidaemia [dsyn] 0.000531093798821
retrospective [resa] 0.000530848037756
Beta-Blockers [phsu] 0.000530581130453
Small [qnco] 0.000530495853571
Bias [idcn] 0.0005294481052
Help [socb] 0.000529248146345
Optimal [qlco] 0.000529132590164
Ischaemic stroke [dsyn] 0.000526732599209
deaths [orgf] 0.000526539449579
Segment [spco] 0.000525915855798
Smoking [inbe] 0.000525416434205
Onset [qlco] 0.000525404532558
Eight [qnco] 0.000524026596389
variables [qlco] 0.000522811093349
With [qlco] 0.000522431176122
computed tomography [diap] 0.000521668166853
Physicians [prog] 0.000521141791001
progression [patf] 0.000519203498531
Guide [prog] 0.000517070849324
surveillance [ftcn] 0.000516942663307
Gender [orga] 0.00051632834494
Pulmonary arterial hypertension [dsyn] 0.000516155648
???lead [elii, hops] 0.000515521366626
Exercise [dora] 0.00051508519691
Complete [qlco] 0.000514754496578
Exposure NOS [inpo] 0.000514222165091
side effects [ftcn] 0.000513300278191
Understanding [menp] 0.00051258266691
Administration [ocac] 0.00051213481354
Decade [qnco] 0.000510535385521
Session [evnt] 0.000510384527995
Clinical Trials [resa] 0.000510110635491
International [idcn] 0.000509596843343
Depression [mobd] 0.000508214020282
Cost [qnco] 0.000507364853654
Standard [qlco] 0.000506376545143
Surgical [hlca] 0.000503861881767
Address [inpr] 0.000502386859357
Few [qnco] 0.00050178750586
Plasma [bdsu] 0.000501573541874
Area [geoa] 0.000500595590918
radiation therapy [inpr] 0.000500524000059
Status [qlco] 0.000499409658352
Advance [medd] 0.000498594369119
Interaction [ftcn] 0.000495655696918
lack [qlco] 0.000494780162222
Affect [menp] 0.000494655772514
Screening [hlca] 0.000494411546055
Data Collection [resa] 0.000492706413912
Values [qlco] 0.000491399693813
prospective [resa] 0.000490503366131
techniques [inpr] 0.00048856792965
Pulmonary Disease, Chronic Obstructive [dsyn] 0.000485159469222
Chronic disease [dsyn] 0.00048242909424
Sample [sbst] 0.000479144515859
Countries [geoa] 0.000477411413346
Doses [qnco] 0.000477318792139
Direct [qlco] 0.000475487423992
High dose [qnco] 0.000472682903873
Risk Ratio [qnco] 0.000472510138333
Best [qlco] 0.000472161551235
Fatal [qlco] 0.000471946655567
Currently [tmco] 0.000471498500008
topic9
P NOS [aapp, imft] 0.00983473036698
treatment [ftcn] 0.00941512842649
Study [mnob] 0.00639077571299
Group [idcn] 0.00539767522867
Cardiovascular disease [dsyn] 0.0053360827669
Women [popg] 0.00516255798554
Mortality [qnco] 0.00471272907892
Methods [inpr] 0.00403189755093
Age [orga] 0.00394901801603
Based [ftcn] 0.00385335639579
Compared [acty] 0.00384405163206
Trial [resa] 0.00363442021731
N NOS [aapp, imft] 0.00305935264725
effects [qlco] 0.00302676238869
Conclusions [idcn] 0.00291602753372
Management [ocac] 0.00288046207169
included [ftcn] 0.0028690997973
Increased [qnco] 0.00280344348146
Including [ftcn] 0.00278124809388
CARDIOVASCULAR [bdsy] 0.00267446638896
radiotherapy [inpr] 0.00259219746123
Heart [bpoc] 0.00257528951486
treated [topp] 0.00251667199386
Efficacy [qlco] 0.00250133247049
therapy [ftcn] 0.00233304695728
Complications [patf] 0.00228200898287
Health [idcn] 0.00227499367409
Hypertension [dsyn] 0.00224695911423
Association [menp] 0.00217177748657
Cardiac [bpoc] 0.00205965003598
participants [popg] 0.00205918676583
months [tmco] 0.0020135018572
Specific [qlco] 0.00196159550126
Prevention [topp] 0.00195491103568
Performed [ftcn] 0.001923654208
Old [tmco] 0.00191701586851
Survival [acty] 0.00191292958925
Men [popg] 0.00191184782947
Cases [ftcn] 0.00188631522721
Stroke [dsyn] 0.00186368192375
effective [qlco] 0.00186016126382
Suggest [idcn] 0.00183425351554
Reserve [acty] 0.00183090496197
Children [aggp] 0.00181406193639
Odds Ratio [qnco] 0.00181394933656
Quality [qlco] 0.0018110120572
Breast Cancer [neop] 0.00180359861674
Care [acty] 0.00178816638143
Reported [inpr] 0.00175687117836
High Risk [qlco] 0.00168119105851
Present [qnco] 0.0016359838619
Diabetes [dsyn] 0.00161233203929
risk factors [qnco] 0.00158264442849
C-reactive protein [aapp, imft] 0.00156779372301
Objective [inpr] 0.00156127872853
Therapeutic [topp] 0.00155057960512
Observed [ftcn] 0.00154818683443
Evaluate [ftcn] 0.00154367630174
Evaluated [ftcn] 0.00153026402702
Dose [qnco] 0.00152806783228
baseline [bodm] 0.00150639381147
Target [ftcn] 0.0015059848454
Identified [qlco] 0.00150539387243
Levels [qlco] 0.00149665463789
Surgery [bmod] 0.00147764366747
Range [qnco] 0.00147007921759
Heart failure [dsyn] 0.00144856769887
Venous malformation [anab] 0.00141593425993
Assessed [acty] 0.0014056385908
Blood Pressure [orgf] 0.00137397509689
Statins [orch, phsu] 0.00137054257033
Primary [qlco] 0.0013615691992
Hazard Ratio [qnco] 0.00136071218975
Atrial Fibrillation [patf] 0.0013447421346
Receive [qlco] 0.00133632610636
Purpose [ftcn] 0.00133455305179
intervention [hlca] 0.00133039003317
Induced [ftcn] 0.0013212540871
Main [qlco] 0.00130042938071
PREVENT [phsu] 0.00129687973053
Adjusted [ftcn] 0.00129381891219
Hormone replacement therapy [topp] 0.00128903940951
Guidelines [inpr] 0.00126785056027
Benefit [qnco] 0.001241406008
Life [idcn] 0.00123416247674
coronary heart disease [dsyn] 0.00123017527329
Controlled [ftcn] 0.00122586309537
findings [ftcn] 0.0012224369971
IMPACT [gngm] 0.001212596788
reduction [npop] 0.00119756893444
Several [qnco] 0.00118855158041
Improved [qlco] 0.00118804358383
Sclerotherapy [topp] 0.00117475550502
Often [tmco] 0.00117278842514
Drugs [phsu] 0.00116032625405
Prognostic Factor [clna] 0.00116012019101
Drug [phsu] 0.00115654391362
interventions [hlca] 0.001149361436
search [inpr] 0.00114145780461
Following [tmco] 0.00112867037746
Limited [ftcn] 0.00112786715436
Appropriate [qlco] 0.00112571510157
Independent [idcn] 0.00112550267533
Improvement [cnce] 0.00112450464098
Need [qlco] 0.00112204133905
Estimated [qnco] 0.00112113209015
Young [tmco] 0.00110910650144
Myocardial Infarction [dsyn] 0.00110594277344
Safety [hcpp] 0.00109963961135
Approach [spco] 0.00109962196729
Available [ftcn] 0.00109445687801
Current [tmco] 0.0010915801032
Statin [orch, phsu] 0.00108931620117
Single [popg] 0.00108507936946
Body Mass Index [diap] 0.00106973466798
Measured [qlco] 0.00106653682592
GY [geoa] 0.00106213279357
Published [ocac] 0.00106093027981
condition [dsyn] 0.00105959408871
Reduced [qlco] 0.00105616823869
Authors [prog] 0.00105200802104
Radiation [npop] 0.00102007773417
lesions [fndg] 0.00101292763087
Irradiation [npop] 0.0010067095474
Update [tmco] 0.00100169027784
Conduct [inbe] 0.000997193121417
Effectiveness [qlco] 0.000985575324986
Design [acty] 0.000984187343044
Long [qlco] 0.000983996368277
Diagnosed [fndg] 0.000979570797879
Evaluation [ftcn] 0.000976879294711
Article [inpr] 0.000967055525726
Metabolic syndrome [dsyn] 0.000952534950716
Likely [qlco] 0.000949702731393
System [ftcn] 0.000948771330543
Average [qnco] 0.000937729282663
ischaemic heart disease [dsyn] 0.000934755387783
Heart disease [dsyn] 0.00092970775782
considered [idcn] 0.000919970266715
Morbidity [qnco] 0.000918620547451
Small [qnco] 0.000912253277825
Survivors [podg] 0.000911271798533
setting [ftcn] 0.000906452048248
Assessment [hlca] 0.000901292308239
Exercise [dora] 0.000900224129345
Select [acty] 0.000894082096587
Five [qnco] 0.000893101243082
Characteristics [qlco] 0.000888877911181
coronary artery disease [dsyn] 0.000887303646554
national [inpr] 0.00088597988714
Severe [qlco] 0.000874124329466
Physical activity [dora] 0.000870973306317
Imaging [diap] 0.000870853310557
Menopause [phsf] 0.000866328973952
Vascular Malformations [anab] 0.000866057646082
Burden [idcn] 0.000859938742569
cardiovascular events [fndg] 0.000859840505046
Medication [phsu] 0.000858072917497
Occurred [acty] 0.00085505799834
Future [tmco] 0.000854687404538
Physicians [prog] 0.000847740901519
Score [qnco] 0.000845525371405
Established [qlco] 0.000845068620934
objectives [inpr] 0.000844675666997
Oral [spco] 0.000843874395602
Obesity [dsyn] 0.000842478894711
Combined [qlco] 0.000841716931903
Smoking [inbe] 0.000841088631778
Combination [qlco] 0.000840248584103
Adherence [ftcn] 0.000839442994437
vascular [bpoc] 0.000839158110441
Information [idcn] 0.000838973351783
practice [menp] 0.000836476451392
days [tmco] 0.000836145095883
Lipid [lipd] 0.000834330026047
In [qnco] 0.000830942401483
Support [medd] 0.000824996655983
Index [inpr] 0.000823375864655
Subject [grup] 0.000821914778848
Examined [fndg] 0.000821185879803
experience [menp] 0.000820094923342
Novel [tmco] 0.000819309438192
Received [qlco] 0.000819052545957
Adult [aggp] 0.000818877674081
Cost Effectiveness [qnco] 0.000817534254174
LTD [ortf] 0.00081356334662
chronic [tmco] 0.000810476803114
Previous [tmco] 0.000807637340843
randomized [resa] 0.000803326360968
symptoms [ftcn] 0.000801197190625
function [phsf] 0.000800530234069
Confidence Intervals [qnco] 0.000798890027607
strategies [menp] 0.000794680127686
rats [mamm] 0.000792289124276
GIVEN [cnce] 0.000792081451876
Needed [qlco] 0.000791829944854
Benefits [qnco] 0.000790018203362
Elderly [popg] 0.000784455334996
Aspirin [orch, phsu] 0.000781590574327
placebo [topp] 0.000777375646021
Acute myocardial infarction [dsyn] 0.000774757815214
Aged [orga] 0.000769332442944
Atherosclerosis [dsyn] 0.000762319666276
Relationship [qlco] 0.000760712128053
Make [ftcn] 0.000758292715474
Comorbidities [idcn] 0.000752280059376
Chronic kidney disease [dsyn] 0.00074620439651
patient care [hlca] 0.000745083391841
Depression [mobd] 0.000743045086321
Required [ftcn] 0.000742783613593
Medications [phsu] 0.000742584813763
Events [evnt] 0.000741890713275
Bleeding [patf] 0.000737315803324
Complex [qlco] 0.000736204179146
Relevant [qlco] 0.000734176496128
History [ocdi] 0.000733717687705
Additional [ftcn] 0.000731608098685
investigated [ftcn] 0.000731185660864
Increasing [ftcn] 0.000728138912295
Drug Therapy [topp] 0.00072319766335
Medical [ftcn] 0.000720935491875
People [popg] 0.000720209502204
Associations [menp] 0.000715535597888
Venous Thromboembolism [patf] 0.000715117978651
Six [qnco] 0.000714509910006
Life Style [socb] 0.000713641530816
Hospital [hcro, mnob] 0.000712645608824
Estrogen [horm, phsu, strd] 0.00071164093643
Female [fndg] 0.000707682736046
prognostic [inpr] 0.000706849213133
Decrease [qlco] 0.000706724210439
Well [qlco] 0.000703499428657
acute [tmco] 0.000701430926009
postmenopausal [tmco] 0.000700843213087
Searched [acty] 0.000698264185278
Addition [ftcn] 0.000688854786897
Therapies [topp] 0.000686026781747
coronary [bpoc] 0.000685843669962
Chemotherapy [topp] 0.000683568690442
Take [hlca] 0.000683352782246
Congenital heart disease [cgab, dsyn] 0.000679934900047
Known [qlco] 0.00067755156834
Control Group [grup] 0.000676537638333
cardiovascular risk factor [dsyn] 0.000676072312507
Plasma [bdsu] 0.000672941076634
Ratio [qnco] 0.000669116785051
Mechanisms [ftcn] 0.000668512149542
Stage [tmco] 0.000666650511395
Large [qnco] 0.000664650370441
Diabetes Mellitus [dsyn] 0.000663297979624
Center [spco] 0.000661167116336
variables [qlco] 0.000659349036093
Treatments [topp] 0.000657319980377
Central [spco] 0.000654669559372
Acute Coronary Syndrome [dsyn] 0.000653500140983
Flow [npop] 0.000651693726115
Defined [cnce] 0.000648228207026
Proportion [qnco] 0.000646939706743
Literature [inpr] 0.000642046645711
Values [qlco] 0.000640568910704
Dyslipidaemia [dsyn] 0.000640056235317
Breast [bpoc] 0.000636123334403
Obtained [ftcn] 0.00063567415932
Measure [qnco] 0.000634706167519
Last [qlco] 0.000634374872693
Understanding [menp] 0.000634148909583
Recommended [idcn] 0.00062848778707
Diseases [dsyn] 0.000625599671095
Second [qnco] 0.000624954368177
lack [qlco] 0.000624634230949
Exposure NOS [inpo] 0.000619446084731
APPEAR [qlco] 0.000616304827853
Focus [spco] 0.000614681358973
Marker [clna] 0.000614567504867
Leading [tmco] 0.000613782163373
hypertensive [fndg] 0.000613755251429
strategy [menp] 0.000612262882425
Test [lbpr] 0.000611703668292
Response [orga] 0.00061120267789
Postoperative [tmco] 0.000610564144557
Ethanol [orch] 0.000606866118119
Multiple [qnco] 0.000602255294509
Issue [fndg] 0.000598519687366
randomized controlled trials [inpr, resa] 0.000598033461117
Alone [qnco] 0.000597737457014
Parameters [fndg] 0.000597380386658
Concern [idcn] 0.00059597839185
Risks [qlco] 0.000588979177908
Relative [famg] 0.000588031607085
Cardiovascular Diseases [dsyn] 0.000586596477884
Profile [lbpr] 0.000585130101906
Address [inpr] 0.000582176597223
Collected [idcn] 0.000582064227382
Sex [orgf] 0.000581755735005
Inflammatory [ftcn] 0.00057656230391
Ischaemic [ftcn] 0.000569762955484
Surgical [hlca] 0.000568844546438
Countries [geoa] 0.000568715154053
Guide [prog] 0.000567110821984
Various [irda] 0.000565859048442
Post [tmco] 0.000562200543298
Normal [qlco] 0.000560151106997
Duration [tmco] 0.000554537774377
Report [inpr] 0.000554382183652
Cardiology [bmod] 0.000551529791936
Cells [cell] 0.000551265090747
Comparison [acty] 0.000551102404459
Revealed [qlco] 0.000550969048075
Regression [patf] 0.000550608219271
Few [qnco] 0.000548067017776
Measures [qnco] 0.000546220440934
Length [qnco] 0.00054549944354
Improving [qlco] 0.000545138413571
weeks [tmco] 0.00054486499499
Diet [food] 0.000544758480796
Late [tmco] 0.000544356066858
Discharge [bdsu] 0.000542842514048
???lead [elii, hops] 0.00054212537416
recommendations [idcn] 0.000541267490943
Decreased [qnco] 0.000539358006827
Eight [qnco] 0.00053839464357
M NOS [aapp, imft] 0.000538137954034
Tool [mnob] 0.000537755085501
Functional [ftcn] 0.000535969008942
Help [socb] 0.000535915141169
American [popg] 0.000535173451709
Damage [inpo] 0.000534036782073
Prostate Cancer [neop] 0.000533256246257
Agent [chvf] 0.000533036140043
reviewed [inpr] 0.000532501160479
deaths [orgf] 0.000529341918197
Dialysis [npop] 0.000527716550934
Arterial [bpoc] 0.000527436610798
Head [blor] 0.000524700354857
Systolic blood pressure [clna] 0.000524320443747
procedures [inpr] 0.000523178305217
Extracted [topp] 0.000520096289136
occurrence [ftcn] 0.000519544359832
Advanced [qlco] 0.000517235450709
Action [ftcn] 0.000515513908272
With [qlco] 0.00051493792994
Administration [ocac] 0.000514530793438
Risk Ratio [qnco] 0.000511917090733
Renal [bpoc] 0.000511647451682
Interaction [ftcn] 0.000507847492256
Died [orgf] 0.000505010562759
Symptomatic [ftcn] 0.000502015211578
Pulmonary arterial hypertension [dsyn] 0.000501718008635
Delivery [topp] 0.000500678090539
activity [dora] 0.000500657042538
Standard [qlco] 0.000500135582775
Fatal [qlco] 0.000498524162667
Estrogens [horm, phsu, strd] 0.000497489072388
Antihypertensive [phsu] 0.000495571701672
Value [qnco] 0.000495395760397
Involving [ftcn] 0.000493280716189
Questionnaire [inpr] 0.000493234076314
If [qlco] 0.000492859755844
secondary [neop] 0.000492838151556
Recently [tmco] 0.000492600370257
side effects [ftcn] 0.000492420061201
Pre-operative [tmco] 0.000492132423978
Ageing [orgf] 0.000489986348002
lowering [spco] 0.000488883097085
mice [mamm] 0.000488265935067
Seven [qnco] 0.000488000379897
Biomarkers [clna] 0.00048709079054
Gender [orga] 0.00048610697809
Status [qlco] 0.000484593516421
investigate [ftcn] 0.000483838254175
Part [spco] 0.000483620872532
Program [cnce] 0.000483583931324
prospective [resa] 0.00048326012056
Provided [acty] 0.000481792471836
PLAN [dsyn] 0.000479314336556
Systemic [ftcn] 0.00047795909809
Derived [qlco] 0.000477917467685
Database [inpr] 0.000477236537432
Pulmonary Disease, Chronic Obstructive [dsyn] 0.000476179581323
retrospective [resa] 0.000475853114525
mmHg [qnco] 0.000475666774243
Elevated [qlco] 0.000474827609647
Area [geoa] 0.000474293229205
Pregnancy [orgf] 0.000473879870063
Decade [qnco] 0.000473687352052
heart rate [clna] 0.000473645097546
Hospitalization [hlca] 0.000472879843348
Routine [qlco] 0.000472385624541
HIV [virs] 0.000472241500928
free [ftcn] 0.000470956053089
Prescription [hlca] 0.000469851616025
Polypharmacy [fndg] 0.000467853704714
Order [inpr] 0.000465454063974
Currently [tmco] 0.000462913997136
Oxidative Stress [comd] 0.000461108671037
Users [humn] 0.000460924406414
Indicated [fndg] 0.000459211887823
Advance [medd] 0.000458846943745
Data Collection [resa] 0.000458708957772
Play [dora] 0.000457375561977
